

    <!DOCTYPE html>
<html class="">

        
<head>
    <title>Recent advances in pharmacological management of... | F1000Research</title>
    <meta charset="utf-8">
    <!--<meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>-->
    <!--<meta lang="$locale">-->
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="google-site-verification" content="9-QVycOO2_ob3Z9QzRmXv2CF08A9oyYXqWyTiVdKPlU" />
    <!-- This is commented out to fix display problems on mobile devices.
    We may use it again once we implement a responsive design that supports native device resolutions.
    <meta name="viewport" content="width=device-width"> -->

    <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1">



    <link rel="alternate" title="Recent articles published in F1000Research" href="/rss" type="application/rss+xml">
            <link rel="alternate" type="application/pdf" title="PDF" href="https://f1000research.com/articles/6-2148/pdf"/>
        <link rel="canonical" href="https://f1000research.com/articles/6-2148" />
    
            <meta name="description" content="Read the original article in full on F1000Research: Recent advances in pharmacological management of urinary incontinence" />
    
            <meta name="og:title" content="F1000Research Article: Recent advances in pharmacological management of urinary incontinence.">
            <meta name="og:description" content="Read the latest article version by Bronagh McDonnell, Lori Ann Birder, at F1000Research.">
            <meta name="og:image" content="/img/sharing/og_research.png">
            <meta name="version-id" content="13637">
            <meta name="article-id" content="12593">
            <meta name="dc.title" content="Recent advances in pharmacological management of urinary incontinence">
            <meta name="dc.description" content="Lower urinary tract symptoms&mdash;in particular, storage disorders (for example, urinary incontinence) as well as bladder underactivity&mdash;are major health-related problems that increase with age. Yet lower urinary tract symptoms remain under-diagnosed and poorly managed, and incontinence has been cited as the major reason for institutionalization in elderly populations and is one of the most common conditions in primary care practice. Although lifestyle and behavior therapy has been used as a useful treatment regimen for urge incontinence, medications (often used as adjunct) can provide additional benefit. This review will include current therapies used for treatment of urinary incontinence.">
            <meta name="dc.subject" content="urinary incontinence">
            <meta name="dc.creator" content="McDonnell, Bronagh">
            <meta name="dc.creator" content="Birder, Lori Ann">
            <meta name="dc.date" content="2017/12/19">
            <meta name="dc.identifier" content="doi:10.12688/f1000research.12593.1">
            <meta name="dc.source" content="F1000Research 2017 6:2148">
            <meta name="dc.format" content="text/html">
            <meta name="dc.language" content="en">
            <meta name="dc.publisher" content="F1000 Research Limited">
            <meta name="dc.rights" content="https://creativecommons.org/licenses/by/3.0/igo/">
            <meta name="dc.type" content="text">
            <meta name="prism.keyword" content="urinary incontinence">
            <meta name="prism.publication.Name" content="F1000Research">
            <meta name="prism.publicationDate" content="2017/12/19">
            <meta name="prism.volume" content="6">
            <meta name="prism.number" content="2148">
            <meta name="prism.versionIdentifier" content="1">
            <meta name="prism.doi" content="10.12688/f1000research.12593.1">
            <meta name="prism.url" content="https://f1000research.com/articles/6-2148">
            <meta name="citation_title" content="Recent advances in pharmacological management of urinary incontinence">
            <meta name="citation_abstract" content="Lower urinary tract symptoms&mdash;in particular, storage disorders (for example, urinary incontinence) as well as bladder underactivity&mdash;are major health-related problems that increase with age. Yet lower urinary tract symptoms remain under-diagnosed and poorly managed, and incontinence has been cited as the major reason for institutionalization in elderly populations and is one of the most common conditions in primary care practice. Although lifestyle and behavior therapy has been used as a useful treatment regimen for urge incontinence, medications (often used as adjunct) can provide additional benefit. This review will include current therapies used for treatment of urinary incontinence.">
            <meta name="citation_description" content="Lower urinary tract symptoms&mdash;in particular, storage disorders (for example, urinary incontinence) as well as bladder underactivity&mdash;are major health-related problems that increase with age. Yet lower urinary tract symptoms remain under-diagnosed and poorly managed, and incontinence has been cited as the major reason for institutionalization in elderly populations and is one of the most common conditions in primary care practice. Although lifestyle and behavior therapy has been used as a useful treatment regimen for urge incontinence, medications (often used as adjunct) can provide additional benefit. This review will include current therapies used for treatment of urinary incontinence.">
            <meta name="citation_keywords" content="urinary incontinence">
            <meta name="citation_journal_title" content="F1000Research">
            <meta name="citation_author" content="Bronagh McDonnell">
            <meta name="citation_author_institution" content="Department of Medicine, University of Pittsburgh School of Medicine, A 1217 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA">
            <meta name="citation_author" content="Lori Ann Birder">
            <meta name="citation_author_institution" content="Department of Medicine, University of Pittsburgh School of Medicine, A 1217 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA">
            <meta name="citation_author_institution" content="Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, A 1217 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA">
            <meta name="citation_publication_date" content="2017/12/19">
            <meta name="citation_volume" content="6">
            <meta name="citation_publication_number" content="2148">
            <meta name="citation_version_number" content="1">
            <meta name="citation_doi" content="10.12688/f1000research.12593.1">
            <meta name="citation_firstpage" content="2148">
            <meta name="citation_pdf_url" content="https://f1000research.com/articles/6-2148/v1/pdf">
    

    
    <link href="/img/favicon-research.ico" rel="shortcut icon" type="image/ico">
    <link href="/img/favicon-research.ico" rel="icon" type="image/ico">

        <link rel="stylesheet" href="/1597255280893/css/mdl/material-design-lite.css" type="text/css" media="all" />
    <link href="https://fonts.googleapis.com/icon?family=Material+Icons" rel="stylesheet">
    <link href="https://fonts.googleapis.com/css?family=Roboto:100,100i,300,300i,400,400i,500,500i,700,700i,900,900i" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/MaterialDesign-Webfont/2.2.43/css/materialdesignicons.min.css" />

        
            
    <link rel="stylesheet" href="/1597255280893/css/F1000Research.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons.css" type="text/css" media="all" />
    <link rel="stylesheet" href="/css/F1000ResearchFontIcons/animation.css" type="text/css" media="all" />

        <!--[if IE 7]><link rel="stylesheet" href="/css/F1000ResearchFontIcons/F1000ResearchFontIcons-ie7.css" media="all" /><![endif]-->

                    <script>dataLayer = [];</script>
        <!-- Google Tag Manager -->
        <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
        new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
        j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
        'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
        })(window,document,'script','dataLayer','GTM-54Z2SBK');</script>
        <!-- End Google Tag Manager -->
    
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.8.1/jquery.min.js"></script>
    <script>window.jQuery || document.write('<script src="/js/vendor/jquery-1.8.1.min.js"><\/script>')</script>
    <script src="/1597255280893/js/vendor/modernizr-2.6.1-respond-1.1.0.min.js"></script>
    <script src="/1597255280893/js/shared_scripts/sticky.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/shared_scripts/menu.js"></script>
    <script src="/1597255280893/js/shared_scripts/navbar.js"></script>
    <script src="/1597255280893/js/shared_scripts/platforms.js"></script>
    <script src="/1597255280893/js/shared_scripts/object-polyfills.js"></script>
            <script src="/1597255280893/js/vendor/lodash.min.js"></script>
        <script>CKEDITOR_BASEPATH='https://f1000research.com/js/ckeditor/'</script>
    <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/plugins.js"></script>
    <script src="/1597255280893/js/shared_scripts/helpers.js"></script>
    <script src="/1597255280893/js/app/research.js"></script>
    <script>window.reactTheme = 'research';</script>
    <script src="/1597255280893/js/public/bundle.js"></script>

    <script src="/1597255280893/js/app/research.ui.js"></script>
    <script src="/1597255280893/js/app/login.js"></script>
    <script src="/1597255280893/js/app/main.js"></script>
    <script src="/1597255280893/js/app/js-date-format.min.js"></script>
    <script src="/1597255280893/js/app/search.js"></script>
    <script src="/1597255280893/js/app/cookies_warning.js"></script>
    <script src="/1597255280893/js/mdl/mdl.min.js"></script>

    <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML"></script>
                <script src="https://f1000researchdata.s3-eu-west-1.amazonaws.com/js/ckeditor.js"></script>
            <script src="/js/ckeditor/adapters/jquery.js"></script>
                <script src="/js/article/article_scrolling_module.js"></script>
            <script src="/js/article/article_stats.js"></script>
            <script src="/js/article/article.js"></script>
            <script src="/js/shared_scripts/referee_timeline_pagination.js"></script>
            <script src="/js/app/text_editor_controller.js"></script>
            <script src="//s7.addthis.com/js/250/addthis_widget.js#pubid=ra-503e5e99593dc42c"></script>
            <script src="/js/article/article_metrics.js"></script>
        
                                                                            <script>
            if (window.location.hash == '#_=_'){
                window.location = window.location.href.split('#')[0]
            }
        </script>

                    
        
    <!-- pixelId: 1641728616063202 :: assetPixelId: 6034867600215 :: funderPixelId:  -->

            <!-- Facebook pixel code (merged with EP GTM code) -->
        <script>
            !function(f,b,e,v,n,t,s){if(f.fbq)return;n=f.fbq=function()

            {n.callMethod? n.callMethod.apply(n,arguments):n.queue.push(arguments)}
            ;if(!f._fbq)f._fbq=n;
            n.push=n;n.loaded=!0;n.version='2.0';n.queue=[];t=b.createElement(e);t.async=!0;
            t.src=v;s=b.getElementsByTagName(e)[0];s.parentNode.insertBefore(t,s)}(window,
            document,'script','https://connect.facebook.net/en_US/fbevents.js');

            fbq('init', '1641728616063202');

            
            fbq('track', "PixelInitialized", {});
        </script>

        <noscript><img height="1" width="1" style="display:none"
            src="https://www.facebook.com/tr?id=1641728616063202&noscript=1&amp;ev=PixelInitialized"
        /></noscript>
        <!-- End Facebook Pixel Code -->
    
                <script>
            (function(h,o,t,j,a,r){
                h.hj=h.hj||function(){(h.hj.q=h.hj.q||[]).push(arguments)};
                h._hjSettings={hjid:917825,hjsv:6};
                a=o.getElementsByTagName('head')[0];
                r=o.createElement('script');r.async=1;
                r.src=t+h._hjSettings.hjid+j+h._hjSettings.hjsv;
                a.appendChild(r);
            })(window,document,'https://static.hotjar.com/c/hotjar-','.js?sv=');
        </script>
    
</head>
<body  class="o-page-container no-js p-article o-layout-reset   ">

    
                            <!-- Google Tag Manager (noscript) -->
        <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-54Z2SBK"
        height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
        <!-- End Google Tag Manager (noscript) -->
    
        
    <div class="o-page">

        <div id="notify-container"></div>
        <div id="pageWarning"></div>
        <div id="pageMessage"></div>
        <div id="pageFooterMessage"></div>

                                <div id="f1r-ga-data" data-name="f1r-ga-data" class="f1r-ga-data"
                data-user-registered="false"
                data-user-module=""
                data-current-path=""
                data-location=""
                data-website="F1000Research"
                data-websiteDisplayName="F1000Research">
            </div>
        
                
        
        <div class="header-wrapper   js-navbar-space ">
                            


    










        
                            
    
            



<nav class="c-navbar js-navbar js-mini-nav js-sticky c-navbar--js-sticky c-navbar--userSite c-navbar__platform-bgcolor  c-navbar--bg-f1000research ">

    <div class="c-navbar__content">

                                <div class="c-navbar__extras">
            <div class="o-wrapper">
                <div class="o-actions o-actions--middle c-navbar__extras-row">
                    <div class="o-actions__primary">
                        
                                            </div>
                                    </div>
            </div>
        </div>

        <div class="o-wrapper t-inverted js-sticky-start">

            <div class="c-navbar__branding-row">
                <div class="c-navbar__row">


                                        
                    <div class="c-navbar__primary u-mr--2">

                                                                                                                                                                                                    <a href="/" class="c-navbar__branding u-ib u-middle"   data-test-id="nav_branding"  >
                                <img class="u-ib u-middle" src="/img/research/F1000Research_white_solid.svg" alt="F1000Research">
                            </a>
                                            </div>

                    <div class="c-navbar__secondary c-navbar__row">


                                                
                                                    <form action="/search" class="-navbar__secondary u-mr--2 c-search-form js-search-form u-hide u-show@navbar">
                                <label for="searchInput" class="c-search-form__label _mdl-layout">
                                    <input name="q" type="search" class="c-search-form__input" id="searchInput" placeholder="Search">
                                    <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                </label>
                            </form>
                        
                                                
                                                    <div class="c-navbar__primary u-hide u-show@navbar">
                                <div class="_mdl-layout c-navbar__cta">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--no-shadow mdl-button--multi-line mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                            </div>
                        

                                                
                        <span class="u-hide@navbar _mdl-layout u-nowrap">

                                                            <button type="button" class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" data-focus="#navbar_mob_search_input" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_search_mob"  ><i class="material-icons">search</i></button>
                            
                                                            <button class="mdl-button mdl-js-button mdl-js-ripple-effect mdl-button--icon mdl-button--multi-line c-navbar__toggle c-navbar__toggle--menu js-navbar-toggle" type="button" data-toggle="navbarMenu" data-target="navbarMenu" aria-controls="navbarMenu" aria-expanded="false" aria-label="Toggle navigation"   data-test-id="nav_menu_toggle_mob"  >
                                    <i class="material-icons c-navbar__toggle-open">menu</i>
                                    <i class="material-icons c-navbar__toggle-close">close</i>
                                </button>
                                                    </span>
                    </div>

                </div>
            </div>

                        
                            <div class="c-navbar__menu-row js-navbar-block is-collapsed" id="navbarMenu">

                                                                                                                                                
                                                                    
                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
                                            

                                                                
                                                                                                                                                                                                                                
                                            
                    <div class="c-navbar__menu-row-content">

                                                                            <div class="u-hide@navbar c-navbar__menu-bar-spacing">
                                <form action="/search" class="c-search-form js-search-form">
                                    <label for="navbar_mob_search_input" class="c-search-form__label _mdl-layout">
                                        <input id="navbar_mob_search_input" name="q" type="search" class="c-search-form__input" placeholder="Search">
                                        <button type="submit" class="c-search-form__submit mdl-button mdl-js-button mdl-button--icon"><i class="material-icons">search</i></button>
                                    </label>
                                </form>
                            </div>
                        
                        <div class="o-actions o-actions--middle">

                            <div class="o-actions__primary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="main-menu"   role="menubar" aria-label="Main Navigation"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/browse/articles" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="0"
                              data-test-id="nav_browse"                              >Browse</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/gateways" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_gatewaysViewAndBrowse"                              >Gateways & Collections</a>

                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="2"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_for-authors"                              >How to Publish</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="How to Publish">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_submit-manuscript"                      href="/for-authors/publish-your-research"
                    role="menuitem"
                    tabindex="0">Submit your Research</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/for-authors/my-submissions"
                    role="menuitem"
                    tabindex="-1">My Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines"                      href="/for-authors/article-guidelines"
                    role="menuitem"
                    tabindex="-1">Article Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-guidelines-new-versions"                      href="/for-authors/article-guidelines-new-versions"
                    role="menuitem"
                    tabindex="-1">Article Guidelines (New Versions)</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_data-guidelines"                      href="/for-authors/data-guidelines"
                    role="menuitem"
                    tabindex="-1">Data Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_asset-guidelines"                      href="/for-authors/posters-and-slides-guidelines"
                    role="menuitem"
                    tabindex="-1">Posters and Slides Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_document-guidelines"                      href="/for-authors/document-guidelines"
                    role="menuitem"
                    tabindex="-1">Document Guidelines</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_article-processing-charges"                      href="/for-authors/article-processing-charges"
                    role="menuitem"
                    tabindex="-1">Article Processing Charges</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_finding-referees"                      href="/for-authors/tips-for-finding-referees"
                    role="menuitem"
                    tabindex="-1">Finding Article Reviewers</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="3"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="-1"
                              data-test-id="nav_about-contact"                              >About</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="About">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_about-page"                      href="/about"
                    role="menuitem"
                    tabindex="0">How it Works</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_referee-guidelines"                      href="/for-referees/guidelines"
                    role="menuitem"
                    tabindex="-1">For Reviewers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_advisoryPanel"                      href="/advisors"
                    role="menuitem"
                    tabindex="-1">Our Advisors</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_policy-page"                      href="/about/policies"
                    role="menuitem"
                    tabindex="-1">Policies</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_glossary-page"                      href="/glossary"
                    role="menuitem"
                    tabindex="-1">Glossary</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_faqs-page"                      href="/faqs"
                    role="menuitem"
                    tabindex="-1">FAQs</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              u-hide u-show@navbar"
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      u-hide u-show@navbar"
                                          data-test-id="nav_for-developers"                      href="/developers"
                    role="menuitem"
                    tabindex="-1">For Developers</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_newsroom-page"                      href="/newsroom"
                    role="menuitem"
                    tabindex="-1">Newsroom</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_contact-page"                      href="/contact"
                    role="menuitem"
                    tabindex="-1">Contact</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="4"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="https://blog.f1000.com/blogs/f1000research/" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                             target="_blank"                                                         tabindex="-1"
                              data-test-id="nav_blog"                              >Blog</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                            <div class="o-actions__secondary">

                                                                
    <ul class="c-menubar c-navbar__menu-bar js-main-menu"   id="secondary-items"   role="menubar" aria-label="My Account"  data-menu-group="navbar" >

        
            
                                                                
                                
                                
                                    <li role="none"
                        data-index="0"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                               c-menubar__item--selected c-navbar__menu-bar-item--parent ">

                        <a href="#" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                         aria-haspopup="true" aria-expanded="false"                             tabindex="0"
                              data-test-id="nav_my-research"                              >My Research</a>

                                                    
    <ul class="c-menu js-menu
                is-collapsed                c-menubar__menu c-navbar__menu"
                  role="menu"
        aria-label="My Research">

        
            
                                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-submissions"                      href="/login?originalPath=/my/submissions"
                    role="menuitem"
                    tabindex="0">Submissions</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-email-alerts"                      href="/login?originalPath=/my/email-alerts"
                    role="menuitem"
                    tabindex="-1">Content and Tracking Alerts</a>

                </li>

                    
            
                
                                
                <li class="c-menu__item js-menu-item
                                              "
                        role="none">

                <a  class="c-menu__link js-menu-link
                                                      "
                                          data-test-id="nav_my-user-details"                      href="/login?originalPath=/my/user-details"
                    role="menuitem"
                    tabindex="-1">My Details</a>

                </li>

                        </ul>
                                            </li>
                
            
        
            
                                                                
                
                                
                                    <li role="none"
                        data-index="1"
                        class="c-menubar__item js-menu-item  c-navbar__menu-bar-item
                                                              ">

                        <a href="/login?originalPath=/articles/6-2148.html" class="c-navbar__menu-bar-link js-menu-link " role="menuitem"
                                                                                    tabindex="-1"
                              data-test-id="nav_sign-in"                              >Sign In</a>

                                            </li>
                
            
        
    </ul>



                            </div>

                                                                                        <div class="_mdl-layout c-navbar__cta u-hide@navbar c-navbar__menu-bar-spacing">
                                    <a class="mdl-button mdl-js-button mdl-button--raised mdl-button--multi-line mdl-button--no-shadow mdl-js-ripple-effect mdl-button--inverted c-navbar__submit" href="/for-authors/publish-your-research"   data-test-id="nav_submit_research_mob"  ><i class="material-icons">file_upload</i>Submit your research</a>
                                </div>
                                                    </div>

                    </div>

                </div>
            
        </div>

    </div>

</nav>
                    </div>

        <div class="content-wrapper o-page__main row ">
            <div id="highlight-area" class="content ">
                





<div id=article-metadata class=hidden> <input type=hidden name=versionId value=13637 /> <input type=hidden id=articleId name=articleId value=12593 /> <input type=hidden id=xmlUrl value="/articles/6-2148/v1/xml"/> <input type=hidden id=xmlFileName value="-6-2148-v1.xml"> <input type=hidden id=article_uuid value=66907a2d-9c15-4477-be93-6478f65d8fc4 /> <input type=hidden id=referer value=""/> <input type=hidden id=meta-article-title value="Recent advances in pharmacological management of urinary incontinence"/> <input type=hidden id=workspace-export-url value="https://sciwheel.com/work/api/import/external?doi=10.12688/f1000research.12593.1"/> <input type=hidden id=versionDoi value="10.12688/f1000research.12593.1"/> <input type=hidden id=usePmcStats value=true /> </div> <main class="o-wrapper p-article__wrapper js-wrapper"> <script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "ScholarlyArticle",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://f1000research.com/articles/6-2148"
  },
  "headline": "Recent advances in pharmacological management of urinary incontinence",
  "datePublished": "2017-12-19T10:49:57",
  "dateModified": "2017-12-19T10:49:57",
  "author": [
    {
      "@type": "Person",
      "name": "Bronagh McDonnell"
    },    {
      "@type": "Person",
      "name": "Lori Ann Birder"
    }  ],
  "publisher": {
    "@type": "Organization",
    "name": "F1000Research",
    "logo": {
      "@type": "ImageObject",
      "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
      "height": 480,
      "width": 60
    }
  },
  "image": {
    "@type": "ImageObject",
    "url": "https://f1000research.com/img/AMP/F1000Research_image.png",
    "height": 1200,
    "width": 150
  },
  "description": "Lower urinary tract symptoms&mdash;in particular, storage disorders (for example, urinary incontinence) as well as bladder underactivity&mdash;are major health-related problems that increase with age. Yet lower urinary tract symptoms remain under-diagnosed and poorly managed, and incontinence has been cited as the major reason for institutionalization in elderly populations and is one of the most common conditions in primary care practice. Although lifestyle and behavior therapy has been used as a useful treatment regimen for urge incontinence, medications (often used as adjunct) can provide additional benefit. This review will include current therapies used for treatment of urinary incontinence."
}
</script> <div class="o-layout o-layout--right-gutter"> <div id=article_secondary-column class="p-article__main o-layout__item u-font-size--legal u-2/3@article not-expanded "> <div class=float-left> <script type="application/ld+json">
  {
    "@context": "http://schema.org",
    "@type": "BreadcrumbList",
    "itemListElement": [
              {
          "@type": "ListItem",
          "position": "1",
          "item": {
            "@id": "https://f1000research.com/",
            "name": "Home"
          }
        },              {
          "@type": "ListItem",
          "position": "2",
          "item": {
            "@id": "https://f1000research.com/browse/articles",
            "name": "Browse"
          }
        },              {
          "@type": "ListItem",
          "position": "3",
          "item": {
            "@id": "https://f1000research.com/articles/6-2148/v1",
            "name": "Recent advances in pharmacological management of urinary incontinence"
          }
        }          ]
  }
  </script> <div class="breadcrumbs js-breadcrumbs"> <a href="/" class=f1r-standard-link>Home</a> <span class=item_separator></span> <a href="/browse/articles" class=f1r-standard-link>Browse</a> <span class=item_separator></span> Recent advances in pharmacological management of urinary incontinence </div> </div> <div class="article-badges-container u-mb--2"> <div class=crossmark-new> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js"></script> <a data-target=crossmark><img height=30 width=150 src="https://crossmark-cdn.crossref.org/widget/v2.0/logos/CROSSMARK_Color_horizontal.svg"/></a> </div> <div id=crossmark-dialog style="display: none;" title=""> <iframe id=crossmark-dialog-frame frameborder=0></iframe> </div> <div class=clearfix></div> </div> <div class=article-interaction-container> <div id=main-article-count-box class=article-count-box> <div class="article-metrics-wrapper metrics-icon-wrapper" data-version-id=13637 data-id=12593 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12593.1" data-recommended="" data-doi="10.12688/f1000research.12593.1" data-f1r-ga-helper="Article Page Metrics (Desktop)"> <span class="metrics-on-browse article-metrics-icon f1r-icon icon-89_metrics"></span> <div class="count-title article-metrics-text">ALL Metrics</div> <div class=js-article-metrics-container></div> </div> <div> <div class=count-delimiter></div> <div title="Total views from F1000Research and PubMed Central"> <div class="count-container view-count js-views-count">-</div> <div class=count-title><span class="count-title-icon count-title-views-icon"></span>Views</div> </div> <div class=download-counts hidden> <div class=count-delimiter></div> <div title="Total downloads from F1000Research and PubMed Central"> <div class="count-container js-downloads-count"></div> <div class=count-title><span class="count-title-icon f1r-icon icon-76_download_file"></span>Downloads</div> </div> </div> </div> </div> <div id=main-article-interaction-box class="article-interaction-box has-control-tab"> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-102_download_pdf"></span> <a href="https://f1000research.com/articles/6-2148/v1/pdf?article_uuid=66907a2d-9c15-4477-be93-6478f65d8fc4" title="Download PDF" class="button-link download pdf-download-helper" target=_blank>Get PDF</a> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-103_download_xml"></span> <a id=download-xml href="#" class="button-link download" title="Download XML">Get XML</a> </div> </div> <div class="article-interaction-info article-page"> <div class="cite-article-popup-wrapper article-page-interaction-box"> <div class="article-interaction-button cite-article-button" title="Cite this article" data-windowref=cite-article-popup-12593-1> <span class="f1r-icon icon-82_quote"></span> <a href="#" class="button-link cite-article-popup-link" title="Cite Article">Cite</a> </div> <div id=cite-article-popup-12593-1 class="popup-window-wrapper is-hidden"> <div class=cite-popup-background></div> <div class="popup-window top-popup cite-this-article-box research-layout"> <div class="popup-window-title small cite-title">How to cite this article</div> <span id=cite-article-text-12593-1 data-test-id=copy-citation_text> <span class="article-title-and-info in-popup">McDonnell B and Birder LA. Recent advances in pharmacological management of urinary incontinence [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2148 (<a class=new-orange href="https://doi.org/10.12688/f1000research.12593.1" target=_blank>https://doi.org/10.12688/f1000research.12593.1</a>) </span> <div class="popup-window-title small margin-top-20 margin-bottom-20 note"> <strong>NOTE:</strong> it is important to ensure the information in square brackets after the title is included in all citations of this article. </div> <div class=float-right> <button class="secondary no-fill orange-text-and-border margin-right-20 close-cite-popup uppercase">Close</button> <button id=copy-citation-details class="secondary orange copy-cite-article-version uppercase js-clipboard" title="Copy the current citation details to the clipboard." data-clipboard-target="#cite-article-text-12593-1" data-test-id=copy-citation_button>Copy Citation Details</button> </div> </div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-76_download_file"></span> <a id=export-citation href="#" class="button-link download" title="Export Citation">Export</a> </div> <div class="modal-window-wrapper is-hidden"> <div id=export-citation-popup class="modal-window padding-20"> <div class=modal-window-close-button></div> <div class=modal-window-title>Export Citation</div> <div class=modal-window-row> <div> <input type=radio name=export-citation-option value=WORKSPACE /> <span class=radio-label>Sciwheel</span> </div> <div> <input type=radio name=export-citation-option value=ENDNOTE /> <span class=radio-label>EndNote</span> </div> <div> <input type=radio name=export-citation-option value=REF_MANAGER /> <span class=radio-label>Ref. Manager</span> </div> <div> <input type=radio name=export-citation-option value=BIBTEX /> <span class=radio-label>Bibtex</span> </div> <div> <input type=radio name=export-citation-option value=PROCITE /> <span class=radio-label>ProCite</span> </div> <div> <input type=radio name=export-citation-option value=SENTE /> <span class=radio-label>Sente</span> </div> </div> <div class=modal-window-footer> <button class=general-white-orange-button id=export-citation-submit>EXPORT</button> </div> <div class=default-error style="display: none;">Select a format first</div> </div> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-90_track"></span> <a class="button-link track-article" data-article-id=12593 id=track-article-signin-12593 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12593?target=/articles/6-2148/v1">Track</a> </div> </div> <div class="article-interaction-info article-page"> <div class="article-interaction-button email-article"> <span class="f1r-icon icon-6_email"></span> <a href="#" class=button-link title="Email this article">Email</a> </div> <div class="email-article-version-container small-tooltip _chrome-fix"> <div class=close-icon><span class="f1r-icon icon-3_close_big"></span></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13637 /> <input name=articleId type=hidden value=12593 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> <div class="article-interaction-info article-page"> <div class=article-interaction-button> <span class="f1r-icon icon-34_share"></span> <a href="#" class="button-link last addthis_button share-article" title="Share this article">Share</a> </div> </div> </div> <div id=article-interaction-control-tab class=article-interaction-control-tab> <div id=hide-article-interaction class=article-interaction-control title="Hide Toolbox">&#9644;</div> <div id=show-article-interaction class="article-interaction-control open" title="Show Toolbox">&#10010;</div> </div> </div> <div class="article-header-information article-page"> <div class="f1r-article-mobile article-heading-bar"></div> <div class="article-type article-display">Review </div> <div class="article-title-and-info article-view highlighted-article" id=anchor-title> <h1>Recent advances in pharmacological management of urinary incontinence</h1><span class=other-info> [version 1; peer review: 2 approved]</span> </div> <div class=article-subtitle></div> <div class=f1r-article-desk> <div class="authors _mdl-layout"><span class="">Bronagh McDonnell<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:lbirder@pitt.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Lori Ann Birder</span></a><a href="https://orcid.org/0000-0002-3393-2256" target=_blank id=author-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=author-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3393-2256</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class="authors _mdl-layout"><span class="">Bronagh McDonnell<sup>1</sup>,&nbsp;</span><span class=""><a href="mailto:lbirder@pitt.edu" title="Send email" class="cauthor research-layout"><span class='f1r-icon icon-6_email orange'></span><span>Lori Ann Birder</span></a><a href="http://orcid.org/0000-0002-3393-2256" target=_blank id=mauthor-orcid-1><span class=orcid-logo-for-author-list></span></a><div class="mdl-tooltip mdl-tooltip--wider" for=mauthor-orcid-1><span class=orcid-logo-for-author-list></span> https://orcid.org/0000-0002-3393-2256</div><sup>1,2</sup></span></div> </div> <div class=f1r-article-mobile> <div class=article-pubinfo-mobile> PUBLISHED 19 Dec 2017 </div> </div> <span class=Z3988 title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info:ofi/fmt:kev:mtx:journal&amp;rft_id=info:doi/10.12688%2Ff1000research.12593.1"></span> <div class=f1r-article-desk> <div class="contracted-details first"> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medicine, University of Pittsburgh School of Medicine, A 1217 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA<br/> <sup>2</sup> Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, A 1217 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA<br/> <p> <div class=margin-bottom> Bronagh McDonnell <br/> <span>Roles: </span> Investigation, Writing – Original Draft Preparation </div> <div class=margin-bottom> Lori Ann Birder <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Review & Editing </div> </p> </div> </div> </div> <div class=f1r-article-mobile> <div class="article-page-section-box margin-bottom-40 research-layout"> <span class=box-title> <span class="f1r-icon icon-85_peer_review"></span> OPEN PEER REVIEW </span> <button class="tertiary grey float-right" data-scrollto=article-reports>DETAILS</button> <div class="status-row referee-reports-container"> REVIEWER STATUS <span class=status-icons> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=29035-29057></span> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved data-refInfo=17235-29058></span> </span> </div> </div> </div> </div> <h2 class="article-headings article-page-abstract" id=anchor-abstract> <span class="f1r-article-mobile-inline abstract-heading-border"></span> Abstract </h2> <div class="article-abstract article-page-general-text-mobile research-layout"> <div class="abstract-text is-expanded"> Lower urinary tract symptoms—in particular, storage disorders (for example, urinary incontinence) as well as bladder underactivity—are major health-related problems that increase with age. Yet lower urinary tract symptoms remain under-diagnosed and poorly managed, and incontinence has been cited as the major reason for institutionalization in elderly populations and is one of the most common conditions in primary care practice. Although lifestyle and behavior therapy has been used as a useful treatment regimen for urge incontinence, medications (often used as adjunct) can provide additional benefit. This review will include current therapies used for treatment of urinary incontinence. </div> <div class=abstract-for-mobile> <div class="margin-top-30 padding-bottom-30 research-layout is-centered"> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border show" style="display: none;"> READ ALL <span class="f1r-icon icon-14_more_small orange vmiddle big"></span> </button> <button class="primary orange-text white-bg bigger-text abstract-expand-button-mobile with-border hide"> READ LESS <span class="f1r-icon icon-10_less_small orange vmiddle big"></span> </button> </div> </div> </div> <div class=clearfix></div> <div class="article-context no-divider"> <div class="article-abstract article-page-general-text-mobile research-layout generated-article-body"> <h2 class=main-title>Keywords</h2> <p class="u-mb--0 u-pb--2"> urinary incontinence </p> </div> </div> <div class=article-information> <span class="info-separation padding-bottom"> <div id=corresponding-author-icon class="email-icon float-left"> <span class="f1r-icon icon-6_email orange"></span> <div id=corresponding-author-window class="margin-top-20 popup-window-wrapper is-hidden"> <div class="popup-window corresponding-authors-popup"> <div class=corresponding-author-container> <div class="popup-window-title small">Corresponding Author(s)</div> <div class=authors> Lori Ann Birder (<a href="mailto:lbirder@pitt.edu">lbirder@pitt.edu</a>) </div> </div> <div class="margin-top margin-bottom float-left"> <button id=close-popup-window class=general-white-orange-button>Close</button> </div> </div> </div> </div> <span class="icon-text float-left" data-test-id=box-corresponding-author> <b>Corresponding author:</b> Lori Ann Birder </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom competing-interests-display"> <span class=competing-interests-title>Competing interests:</span> No competing interests were disclosed. </span> <div class="info-separation padding-bottom grant-information-display"> <span class=grant-information-title>Grant information:</span> The author(s) declared that no grants were involved in supporting this work. </div> <span class="f1r-article-desk info-separation padding-bottom"> <span class="copywrite-icon float-left"> <span class="f1r-icon icon-100_open_access"></span> </span> <span class="icon-text float-left" data-test-id=box-copyright-text> <b>Copyright:</b>&nbsp; © 2017 McDonnell B and Birder LA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </span> <div class=clearfix></div> </span> <span class="info-separation padding-bottom" data-test-id=box-how-to-cite> <b>How to cite:</b> <span class="article-title-and-info in-article-box"> McDonnell B and Birder LA. Recent advances in pharmacological management of urinary incontinence [version 1; peer review: 2 approved]</span>. <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2148 (<a href="https://doi.org/10.12688/f1000research.12593.1" target=_blank>https://doi.org/10.12688/f1000research.12593.1</a>) </span> <span class=info-separation data-test-id=box-first-published><b>First published:</b> 19 Dec 2017, <b>6</b>(F1000 Faculty Rev):2148 (<a href="https://doi.org/10.12688/f1000research.12593.1" target=_blank>https://doi.org/10.12688/f1000research.12593.1</a>)</span> <span class=info-separation data-test-id=box-latest-published><b>Latest published:</b> 19 Dec 2017, <b>6</b>(F1000 Faculty Rev):2148 (<a href="https://doi.org/10.12688/f1000research.12593.1" target=_blank>https://doi.org/10.12688/f1000research.12593.1</a>)</span> </div> <div class=clearfix></div> <div id=article-context class=article-context> <div id=article1-body class=generated-article-body><h2 class=main-title id=d12713e162>Introduction</h2><p class="" id=d12713e165>Urinary incontinence (UI), alone or as an overactive bladder (OAB) symptom, is a growing global health-care problem that increases in prevalence with age<sup><a href="#ref-1">1</a>–<a href="#ref-3">3</a></sup>. UI is 1.5 times more common in women than men, affecting approximately 45% and 77% of adult males and females, respectively, in the US, the UK, and Sweden<sup><a href="#ref-4">4</a></sup>. Both severity and frequency of UI significantly increase mortality among men and women<sup><a href="#ref-5">5</a></sup>. An industry report recently predicted a 2.9% global market growth rate of pharmacological treatments for OAB from 2017 to 2022 and projected a total cost of USD $4.19 billion by the year 2020<sup><a href="#ref-6">6</a></sup>. Despite its widespread prevalence and socioeconomic burden, incontinence therapy remains limited and often accompanied by significant adverse effects (AEs), low efficacy, and high discontinuation rates<sup><a href="#ref-7">7</a>,<a href="#ref-8">8</a></sup>. In addition, there is surprisingly little information regarding biomarkers that can identify age-induced bladder dysfunction or patient response to treatment. There is a growing and pervasive need for pharmacologic therapies that are efficacious, safe, and tolerable. Efforts in the past three years have identified potential new targets in addition to combination therapies or adding a non-pharmacological intervention or both. This article will highlight advances within the last three years regarding current pharmacological treatments for both urge UI (UUI) and stress UI (SUI).</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12713e197>UI subtypes</h2><p class="" id=d12713e200>Clinical and basic science has classified UI into subtypes based on pathophysiology and causal factors. The most bothersome subtype reported by women is UUI<sup><a href="#ref-4">4</a>,<a href="#ref-9">9</a></sup> whereas the most prevalent subtype is SUI<sup><a href="#ref-4">4</a>,<a href="#ref-10">10</a></sup>. The pathophysiology underlying UUI is complex and based on altered physiological mechanisms controlling bladder storage and emptying. Causal factors have been focused on myogenic, neurogenic, and (more recently) sensory dysfunction (see review <a href="#ref-11">11</a>). SUI is urinary leakage due to increased abdominal pressure caused by sneezing, coughing, exercise, lifting, and position change. Its pathophysiology, compared with that of UUI, may be less complex and largely related to physical changes in structures forming or in relation to the lower urinary tract (for example, the pelvic floor muscles). A large proportion of women experience mixed urinary incontinence (MUI), which includes both UUI and SUI symptoms. Studies have reported MUI alone to affect 2–4 out of 10 women who are from 20 to more than 80 years old<sup><a href="#ref-4">4</a>,<a href="#ref-9">9</a></sup>. Following clinical determination of urge or stress incontinence, a number of treatment regimens can be followed. Deciding on a treatment regimen is a multi-factorial decision process dictated in part by UI subtype and symptom severity.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12713e230>Pharmacological management for urge incontinence</h2><p class="" id=d12713e233>Anti-muscarinic (anti-cholinergic) drugs remain the most widely used treatment option for UUI and often are used in primary care in combination with behavioral and lifestyle changes, which can include pelvic floor muscle training exercises or reduction of caffeine intake or both. An unfavorable balance between efficacy and tolerability of anti-muscarinic agents, despite their widespread use, exists and has raised questions regarding the overall benefits derived from use of these agents. Furthermore, caution regarding use of anti-muscarinics is recommended in frail elderly patients because of an increased risk of cognitive impairment<sup><a href="#ref-12">12</a>,<a href="#ref-13">13</a></sup>. Oxybutynin is the most widely prescribed anti-muscarinic for UUI<sup><a href="#ref-14">14</a></sup>. Other drugs, such as β3-agonists and phosphodiesterase 5 (PDE5) inhibitors, are available and may have fewer unwanted AEs but have not been shown to be any more effective in improving storage lower urinary tract symptoms. Several advances are being made to reduce anti-cholinergic side effects primarily by creating receptor-selective agents, altering formulation or administration (or both), thus minimizing AEs caused by systemic antagonism of cholinergic receptors.</p><p class="" id=d12713e247>Currently licensed anti-muscarinics indicated for incontinence include orally prescribed oxybutynin, tolterodine, and trospium available as immediate release (IR) and extended release (ER) formulations. In addition, US Food and Drug Administration (FDA)-approved anti-muscarinics include fesoterodine, darifenacin, and solifenacin as oral IR formulations. Propiverine is an oral anti-muscarinic approved in Asia and recently in Canada and is awaiting FDA approval for the US<sup><a href="#ref-11">11</a></sup>. Oxybutynin is the most widely available anti-muscarinic in the US, where it is also available in oral ER and transdermal formulations<sup><a href="#ref-13">13</a></sup>.</p><p class="" id=d12713e258>Transdermal formulations of oxybutynin and tolterodine were introduced in 2007 to avoid/minimize systemic AEs associated with oral treatments. A comparison study in 2017 involving 1,530 patients (more than 20 years old) with OAB assessed efficacy and toxicity at 12 weeks between the oxybutynin patch and oral propiverine (20 mg). The authors reported non-inferiority in terms of reducing the number of incontinence episodes (urge or total incontinence). While a greater incidence of AEs was reported with oxybutynin patch versus propiverine group (74.8% versus 64.9%), the incidence of dry mouth or constipation was reduced more than 50% compared with propiverine. The predominant AE associated with the patch, which affected 40.2% of patients, was dermatitis and was reportedly mild in the majority of cases; 26.7% of the affected group (10.7% total) continued treatment with topical steroidal treatment<sup><a href="#ref-15">15</a></sup>. A phase 3 study assessed the efficacy and safety of once-daily applied oxybutynin transdermal gel 3% (OTG3%) (84 or 56 mg) or placebo in 624 adult patients with OAB-UUI. At 12 weeks, OTG3% 84 mg reduced the weekly number of incontinence episodes (urge and mixed) compared with placebo (difference from baseline, -20.4 versus -18.1, respectively). The study concluded that OTG3% 84 mg/day was well tolerated and effective in this adult population<sup><a href="#ref-16">16</a></sup>. Lastly, a large meta-analysis in women with OAB found that long-acting oxybutynin formulations (oral, patch, and gel), compared with IR, were more effective, had a lower incidence of AEs, and were better tolerated<sup><a href="#ref-17">17</a></sup>.</p><p class="" id=d12713e273>Little evidence is available to support the long-term use of anti-muscarinics. Besides the typical systemic effects which can include dry mouth, constipation, and blurry vision, increasing new evidence indicates that cumulative anti-muscarinic use is associated with an increase in incident dementia<sup><a href="#ref-18">18</a></sup> as well as mood disorders, including depression<sup><a href="#ref-19">19</a></sup>. These findings support earlier reports of associated depression with short-term anti-muscarinic treatment<sup><a href="#ref-20">20</a></sup>. The new knowledge of incident dementia and mood disorders warrants careful consideration by clinicians and patients when considering treatment options for incontinence, particularly in elderly patients and those with neurobiological disease such as multiple sclerosis and Alzheimer’s disease. In the past three years, clinicians have created FORTA (Fit fOR The Aged), a clinical tool to help aid decision making regarding appropriateness of pharmacotherapies in elderly patients often being treated for multiple conditions<sup><a href="#ref-21">21</a></sup>.</p><div class=section><a name=d12713e293 class=n-a></a><h3 class=section-title>Children</h3><p class="" id=d12713e298>Anti-muscarinics are the main pharmacological treatment for children (&lt;12 years) when non-pharmacological or neuromodulation or both are not effective, usually in severe cases<sup><a href="#ref-22">22</a></sup>. Oxybutynin IR and ER (dosing 0.3–0.6 mg/kg per day daily dose, not exceeding 15 mg/day total) are the only currently FDA-approved anti-muscarinics for treatment of OAB symptoms in children. Newer anti-muscarinics have not yet been approved but are prescribed off-label in treatment-resistant children. In these cases, tolterodine and solifenacin have shown comparable efficacy with fewer side effects<sup><a href="#ref-22">22</a></sup>. Propiverine (oral) (0.4–0.8mg/kg per day in two doses) is approved for children in other countries, including Japan<sup><a href="#ref-23">23</a></sup>. Trials in children have reported efficacy in reducing incontinence with an acceptable tolerability using propiverine open-label<sup><a href="#ref-24">24</a>,<a href="#ref-25">25</a></sup> and trospium<sup><a href="#ref-26">26</a></sup>. Oxybutynin transdermal patches may offer a viable alternative to oral oxybutynin, reducing AEs and difficulty of dosing, in children with OAB symptoms, including incontinence<sup><a href="#ref-27">27</a></sup>. Solifenacin seems a promising drug option for children and adolescents with incontinence as part of OAB and non-neurogenic detrusor overactivity and those refractory to other anti-muscarinics (oxybutynin and tolterodine treatment). Nadeau <i>et al</i>. have reported efficacy using solifenacin in children as part of a dual anti-muscarinic therapy approach<sup><a href="#ref-28">28</a></sup>. In addition, a phase 3 placebo-controlled trial concluded a clinically relevant improvement in mean voided volume in children at 12 weeks following once-daily treatment with solifenacin oral suspension<sup><a href="#ref-29">29</a></sup>. This study was one of the first to report long-term use of solifenacin in 119 children/adolescents compared with placebo, reporting improvement in incontinence by 3 weeks (change from baseline) which was maintained for the study period (52 weeks)<sup><a href="#ref-30">30</a></sup>. Further studies are needed to establish efficacy, safety, and tolerability compared with placebo and other anti-muscarinics.</p></div><div class=section><a name=d12713e345 class=n-a></a><h3 class=section-title>Beta-adrenergic receptor agonists</h3><p class="" id=d12713e350>Mirabegron, a β3-adrenoceptor (AR) agonist, is a first-in-its-class drug approved for the treatment of OAB with symptoms of UUI, urgency, and urinary frequency<sup><a href="#ref-31">31</a>,<a href="#ref-32">32</a></sup>. This drug is associated with improved bladder compliance, increased bladder capacity, reduced urinary frequency, and reduced incontinence<sup><a href="#ref-32">32</a></sup>. Recent evidence has suggested that mirabegron may relax the smooth muscle via a dual mechanism of action which includes activation of β3-AR in addition to blockade α1-AR<sup><a href="#ref-33">33</a>,<a href="#ref-34">34</a></sup>. It is acknowledged that long-term toxicity and efficacy, compared with those of standard treatment, remain to be established.</p><p class="" id=d12713e371>In phase II and III clinical trials, mirabegron was found to be efficacious in reducing OAB symptoms as well as reducing the number of incontinence episodes. Improvement was found to be maintained throughout treatment (up to 12 months) and appeared to be well tolerated in patients, including those at least 65 years old<sup><a href="#ref-35">35</a>,<a href="#ref-36">36</a></sup>. A recent <i>post hoc</i> analysis of three phase III randomized control trials (RCTs) in women with OAB-incontinence concluded a significant improvement in the number of incontinence episodes with mirabegron versus placebo and established a greater treatment effect with increasing severity of incontinence<sup><a href="#ref-37">37</a></sup>. These results raise the possibility that mirabegron is more effective in severe forms of OAB-incontinence and thus may provide a preferred treatment option for these patients. Available evidence would suggest that it offers an effective alternative to anti-muscarinic therapy<sup><a href="#ref-38">38</a></sup>.</p><p class="" id=d12713e392>A large meta-analysis of 44 RCTs of 27,309 patients concluded that mirabegron (50 mg) has similar efficacy to most anti-muscarinic drugs but with fewer incidences of AEs, particularly dry mouth, which is the most frequently reported anti-muscarinic AE and reason for discontinuation among patients<sup><a href="#ref-39">39</a></sup>. Further head-to-head comparisons between mirabegron and anti-muscarinic drugs are necessary to compare efficacy and safety. Notably, mirabegron appears effective in adult patients who are refractory to or unsuitable for anti-muscarinic therapy<sup><a href="#ref-35">35</a></sup>. This finding is further supported by a recent phase III, multicenter, open-label RCT in Japan, where the authors reported long-term (52 weeks) efficacy and safety of mirabegron in patients with OAB. The majority of patients remained on 50 mg treatment with concomitant improvement in all domains of quality of life (QOL) scores<sup><a href="#ref-40">40</a></sup>.</p><p class="" id=d12713e407>Mirabegron is not currently licensed for use in children; however, it is prescribed open-label for various types of incontinence, including nocturnal enuresis and daytime incontinence. Safety and efficacy in children remain to be confirmed. Two open-label trials in Canada have shown mirabegron to be effective and safe in children (ages 5 to 17 years) with OAB-incontinence/enuresis<sup><a href="#ref-41">41</a>,<a href="#ref-42">42</a></sup>. Blais <i>et al</i>. (2016) reported improvement in continence and QOL in children/adolescents with refractory OAB and unsatisfactory management of symptoms with anti-muscarinic therapy<sup><a href="#ref-41">41</a></sup>. The second trial reported mirabegron to be beneficial as an add-on therapy along with anti-muscarinic therapy, again in children with refractory OAB. The addition of mirabegron to the treatment schedule was well tolerated and appeared to be safe<sup><a href="#ref-42">42</a></sup>.</p></div><div class=section><a name=d12713e429 class=n-a></a><h3 class=section-title>Combination therapy</h3><p class="" id=d12713e434>Combination therapy using an anti-cholinergic agent coupled with mirabegron has also been used. Several phase III trials in the past three years have assessed its efficacy and safety as add-on to anti-muscarinic treatment (dual therapy). The phase II randomized control SYMPHONY trial (2015) assessed combination mirabegron 25 or 50 mg and solifenacin 5 or 10 mg in women with OAB<sup><a href="#ref-43">43</a></sup>. In a follow-up study, SYMPHONY II, Abrams <i>et al</i>. reported improvement in objective and subjective efficacy outcomes with combination mirabegron 25/50 mg and solifenacin 5/10 mg compared with placebo or solifenacin 5 mg alone<sup><a href="#ref-44">44</a></sup>. Herschorn <i>et al</i>. evaluated solifenacin 5 mg combined with mirabegron 25 or 50 mg and found superior efficacy in patients with OAB-UI<sup><a href="#ref-45">45</a></sup>. The effect size (from baseline) in both treatment groups compared with placebo was superior to either therapy alone<sup><a href="#ref-45">45</a></sup>. Only one phase IV trial, performed in Japan, confirmed that mirabegron was effective as an add-on therapy to anti-muscarinic treatment<sup><a href="#ref-46">46</a></sup>. This study (MILAI) assessed mirabegron (25 or 50 mg) with solifenacin (2.5 or 5 mg) over 16 weeks in 223 patients (at least 20 years old) with OAB. The authors reported significant improvements in mean number of UI or UUI episodes per 24 hours, OAB symptom score, and QOL-related scores in all treatment groups.</p></div><div class=section><a name=d12713e465 class=n-a></a><h3 class=section-title>Endocannabinoids</h3><p class="" id=d12713e470>Early studies demonstrated that cannabis had therapeutic benefit on urgency incontinence in patients with multiple sclerosis. Constitutively active fatty acid amide hydrolase (FAAH) is the enzyme that breaks down endogenous cannabinoids which are released ‘on demand’ and can target cannabinoid and vanilloid receptors all of which play a role in bladder dysfunction. Thus, targeting FAAH (inhibitors/inactivators) may have a number of therapeutic applications, including treatment of bladder dysfunction and incontinence. A number of animal studies have shown that inhibition of FAAH has benefit in normalizing a number of urodynamic parameters in experiment bladder disorders (see review <a href="#ref-47">47</a>). Although pre-clinical studies have shown a potential benefit of FAAH inhibitors, recent evidence involving a phase I study in healthy human volunteers had revealed a number of off-target AEs showing that the drug was not safe to use in human studies<sup><a href="#ref-48">48</a></sup>. This also indicates a cautionary note whereby more extensive pre-clinical screening (including in human cells) for off-target effects may help to identify potential risks.</p></div></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12713e484>Pharmacological management for stress incontinence</h2><p class="" id=d12713e487>SUI is the involuntary leakage of urine on exertion, sneezing, or coughing<sup><a href="#ref-49">49</a></sup>. In clinical practice, the most efficacious approach to reduce the number of incontinence episodes is to increase musculature tone in the pelvic region (pelvic floor muscles) with exercise<sup><a href="#ref-12">12</a>,<a href="#ref-50">50</a></sup>. Although data supporting long-term use are limited, α1-AR antagonists have been used to increase urethral tone to ensure continued closure during episodes of increased pressure. Alternative drugs such as β2-AR agonists have been used in Japan for SUI treatment<sup><a href="#ref-23">23</a></sup>.</p><p class="" id=d12713e505>Studies report an increased risk of pelvic floor disorders after menopause and this may be linked to estrogen deficiency; thus, estrogen therapy may be beneficial in improving SUI in post-menopausal women. A meta-analysis of clinical trial data rated the evidence for efficacy of estrogen in reducing incontinence as low but well tolerated, much more so than alternative drugs for OAB/incontinence<sup><a href="#ref-51">51</a>,<a href="#ref-52">52</a></sup>. The route of administration appears to be very important as recently concluded by a Cochrane review. The authors reported worsening of UI with systemic estrogen versus an improvement in UI when estrogen was applied locally<sup><a href="#ref-53">53</a></sup>. Conversely, the addition of vaginal estrogen to IR or ER tolterodine did not improve urinary symptoms more than tolterodine alone<sup><a href="#ref-51">51</a></sup>. In addition, vaginal estrogen has been shown to normalize the microbiota and bladder function, making the case for preventive treatment<sup><a href="#ref-54">54</a>,<a href="#ref-55">55</a></sup>. Current guidelines suggest the use of estrogen as an adjunct therapy<sup><a href="#ref-51">51</a></sup>.</p><p class="" id=d12713e534>Duloxetine is a dual serotonin and noradrenaline reuptake inhibitor currently approved in Canada, the US, and Europe for depression. In 2004, duloxetine, under the trade name Yentreve, was approved and licensed in Europe as an add-on therapy for SUI<sup><a href="#ref-56">56</a></sup>. Despite reported efficacy in US and Canadian phase III trials<sup><a href="#ref-57">57</a>,<a href="#ref-58">58</a></sup>, licensing in the US and Canada failed because of concerns over incident suicidality. The FDA reported a doubling in suicide attempts in women receiving the drug for SUI compared with that in the general population (see product information at: <a target=xrefwindow href="https://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/ucm328101.pdf" id=d12713e547>https://www.fda.gov/downloads/drugs/developmentapprovalprocess/developmentresources/ucm328101.pdf</a>). An independent analysis of the dataset used by the European Medicines Agency to license duloxetine was performed by a Canadian research group specifically assessing psychological disturbances. The authors concluded that the risks outweighed the benefits, thus raising concerns regarding the rationale for duloxetine use for treatment of SUI<sup><a href="#ref-59">59</a>,<a href="#ref-60">60</a></sup>. As of 2013, National Institute for Health and Care Excellence guidelines recommend duloxetine (Yentreve) as a second-line therapy in place of surgery for women with SUI, and counseling on expected AEs is advised<sup><a href="#ref-61">61</a></sup>.</p></div><div id=article1-body class=generated-article-body><h2 class=main-title id=d12713e565>Conclusions</h2><p class="" id=d12713e568>In terms of pharmacologic treatment for UI, many drugs exhibit poor efficacy and increased incidence of AEs. Alternative approaches such as the herbal medicine drug AOBO-001 have been introduced for OAB-incontinence and frequency in adults, and a phase II clinical trial is under way to study efficacy in adults with urge incontinence. There is a need for development of new therapeutic approaches, especially in terms of SUI, which have limited options. However, given the recent examples of off-target effects, one should carefully consider increased patient vulnerability to toxicity and AEs due to change in organ function which presents more opportunity for drug-disease interactions.</p></div><div id=article1-back class=generated-article-footer><div class=back-section><a name=d12713e1 class=n-a></a><h2 class=main-title id=d12902>Competing interests</h2><p class=metadata-entry><a name=d12713e99 class=n-a></a><p id=d12713e100> No competing interests were disclosed.</p></p></div><div class=back-section><a name=d12713e1 class=n-a></a><h2 class=main-title id=d12904>Grant information</h2><p>The author(s) declared that no grants were involved in supporting this work.</p></div><div class=back-section><a name=d12713e575 class=n-a></a><span class="research-layout prime-recommended-wrapper reference-heading"><span class="f1r-icon icon-79_faculty_recommended_badge red vmiddle default-cursor"></span><span class="prime-red big">F1000 recommended</span></span><h2 class=main-title id=d13098>References</h2><div class="section ref-list"><a name=d12713e575 class=n-a></a><ul><li><a name=ref-1 class=n-a></a><span class=label>1. </span>&nbsp;<span class=citation><a name=d12713e582 class=n-a></a>Zhang L, Zhu L, Xu T, <i> et al.</i>: A Population-based Survey of the Prevalence, Potential Risk Factors, and Symptom-specific Bother of Lower Urinary Tract Symptoms in Adult Chinese Women. <i>Eur Urol.</i> 2015; <b>68</b>(1): 97–112. <a target=xrefwindow id=d12713e593 href="http://www.ncbi.nlm.nih.gov/pubmed/25572826">PubMed Abstract </a> | <a target=xrefwindow id=d12713e596 href="http://dx.doi.org/10.1016/j.eururo.2014.12.012">Publisher Full Text </a></span></li><li><a name=ref-2 class=n-a></a><span class=label>2. </span>&nbsp;<span class=citation><a name=d12713e605 class=n-a></a>de Ridder D, Roumeguère T, Kaufman L: Overactive bladder symptoms, stress urinary incontinence and associated bother in women aged 40 and above; a Belgian epidemiological survey. <i>Int J Clin Pract.</i> 2013; <b>67</b>(3): 198–204. <a target=xrefwindow id=d12713e613 href="http://www.ncbi.nlm.nih.gov/pubmed/23409688">PubMed Abstract </a> | <a target=xrefwindow id=d12713e616 href="http://dx.doi.org/10.1111/ijcp.12015">Publisher Full Text </a></span></li><li><a name=ref-3 class=n-a></a><span class=label>3. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727501484"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e625 class=n-a></a>Schreiber Pedersen L, Lose G, Høybye MT, <i> et al.</i>: Prevalence of urinary incontinence among women and analysis of potential risk factors in Germany and Denmark. <i>Acta Obstet Gynecol Scand.</i> 2017; <b>96</b>(8): 939–48. <a target=xrefwindow id=d12713e636 href="http://www.ncbi.nlm.nih.gov/pubmed/28401541">PubMed Abstract </a> | <a target=xrefwindow id=d12713e639 href="http://dx.doi.org/10.1111/aogs.13149">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727501484">F1000 Recommendation</a></span></li><li><a name=ref-4 class=n-a></a><span class=label>4. </span>&nbsp;<span class=citation><a name=d12713e652 class=n-a></a>Coyne KS, Kvasz M, Ireland AM, <i> et al.</i>: Urinary incontinence and its relationship to mental health and health-related quality of life in men and women in Sweden, the United Kingdom, and the United States. <i>Eur Urol.</i> 2012; <b>61</b>(1): 88–95. <a target=xrefwindow id=d12713e663 href="http://www.ncbi.nlm.nih.gov/pubmed/21831517">PubMed Abstract </a> | <a target=xrefwindow id=d12713e666 href="http://dx.doi.org/10.1016/j.eururo.2011.07.049">Publisher Full Text </a></span></li><li><a name=ref-5 class=n-a></a><span class=label>5. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726501898"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e675 class=n-a></a>John G, Bardini C, Combescure C, <i> et al.</i>: Urinary Incontinence as a Predictor of Death: A Systematic Review and Meta-Analysis. <i>PLoS One.</i> 2016; <b>11</b>(7): e0158992. <a target=xrefwindow id=d12713e686 href="http://www.ncbi.nlm.nih.gov/pubmed/27410965">PubMed Abstract </a> | <a target=xrefwindow id=d12713e689 href="http://dx.doi.org/10.1371/journal.pone.0158992">Publisher Full Text </a> | <a target=xrefwindow id=d12713e693 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4943733">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726501898">F1000 Recommendation</a></span></li><li><a name=ref-6 class=n-a></a><span class=label>6. </span>&nbsp;<span class=citation><a name=d12713e707 class=n-a></a>MarketsandMarkets: Overactive Bladder Treatment Market by Pharmacotherapy (Anticholinergic- Solifenacin, Oxybutynin, Fesoterodine, Darifenacin; Mirabegron; BOTOX; Neurostimulation), Disease Type (Idiopathic and Neurogenic Bladder Overactivity) - Global Forecast to 2022. Report No. PH 5449, 244 (US). 2017.<a target=xrefwindow id=d12713e709 href="https://www.giiresearch.com/report/mama536515-overactive-bladder-treatment-market-by.html">Reference Source</a></span></li><li><a name=ref-7 class=n-a></a><span class=label>7. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727070310"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e718 class=n-a></a>Vouri SM, Kebodeaux CD, Stranges PM, <i> et al.</i>: Adverse events and treatment discontinuations of antimuscarinics for the treatment of overactive bladder in older adults: A systematic review and meta-analysis. <i>Arch Gerontol Geriatr.</i> 2017; <b>69</b>: 77–96. <a target=xrefwindow id=d12713e729 href="http://www.ncbi.nlm.nih.gov/pubmed/27889591">PubMed Abstract </a> | <a target=xrefwindow id=d12713e732 href="http://dx.doi.org/10.1016/j.archger.2016.11.006">Publisher Full Text </a> | <a target=xrefwindow id=d12713e736 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5516911">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727070310">F1000 Recommendation</a></span></li><li><a name=ref-8 class=n-a></a><span class=label>8. </span>&nbsp;<span class=citation><a name=d12713e749 class=n-a></a>Kim TH, Lee KS: Persistence and compliance with medication management in the treatment of overactive bladder. <i>Investig Clin Urol.</i> 2016; <b>57</b>(2): 84–93. <a target=xrefwindow id=d12713e757 href="http://www.ncbi.nlm.nih.gov/pubmed/26981589">PubMed Abstract </a> | <a target=xrefwindow id=d12713e760 href="http://dx.doi.org/10.4111/icu.2016.57.2.84">Publisher Full Text </a> | <a target=xrefwindow id=d12713e763 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4791665">Free Full Text </a></span></li><li><a name=ref-9 class=n-a></a><span class=label>9. </span>&nbsp;<span class=citation><a name=d12713e772 class=n-a></a>Ebbesen MH, Hunskaar S, Rortveit G, <i> et al.</i>: Prevalence, incidence and remission of urinary incontinence in women: longitudinal data from the Norwegian HUNT study (EPINCONT). <i>BMC Urol.</i> 2013; <b>13</b>: 27. <a target=xrefwindow id=d12713e783 href="http://www.ncbi.nlm.nih.gov/pubmed/23721491">PubMed Abstract </a> | <a target=xrefwindow id=d12713e786 href="http://dx.doi.org/10.1186/1471-2490-13-27">Publisher Full Text </a> | <a target=xrefwindow id=d12713e790 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3674916">Free Full Text </a></span></li><li><a name=ref-10 class=n-a></a><span class=label>10. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726142041"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e799 class=n-a></a>McKenzie S, Watson T, Thompson J, <i> et al.</i>: Stress urinary incontinence is highly prevalent in recreationally active women attending gyms or exercise classes. <i>Int Urogynecol J.</i> 2016; <b>27</b>(8): 1175–84. <a target=xrefwindow id=d12713e810 href="http://www.ncbi.nlm.nih.gov/pubmed/26864664">PubMed Abstract </a> | <a target=xrefwindow id=d12713e813 href="http://dx.doi.org/10.1007/s00192-016-2954-3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726142041">F1000 Recommendation</a></span></li><li><a name=ref-11 class=n-a></a><span class=label>11. </span>&nbsp;<span class=citation><a name=d12713e826 class=n-a></a>Aoki Y, Brown HW, Brubaker L, <i> et al.</i>: Urinary incontinence in women. <i>Nat Rev Dis Primers.</i> 2017; <b>3</b>: 17042. <a target=xrefwindow id=d12713e837 href="http://www.ncbi.nlm.nih.gov/pubmed/28681849">PubMed Abstract </a> | <a target=xrefwindow id=d12713e840 href="http://dx.doi.org/10.1038/nrdp.2017.42">Publisher Full Text </a></span></li><li><a name=ref-12 class=n-a></a><span class=label>12. </span>&nbsp;<span class=citation><a name=d12713e850 class=n-a></a>National Collaborating Centre for Women's and Children's Health: Urinary Incontinence in Women: The Management of Urinary Incontinence in Women. Royal College of Obstetricians and Gynaecologists 2013 National Collaborating Centre for Women's and Children's Health. 2013. <a target=xrefwindow id=d12713e852 href="http://www.ncbi.nlm.nih.gov/pubmed/25340217">PubMed Abstract </a></span></li><li><a name=ref-13 class=n-a></a><span class=label>13. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717967661"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e861 class=n-a></a>Gormley EA, Lightner DJ, Burgio KL, <i> et al.</i>: Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. <i>J Urol.</i> 2012; <b>188</b>(6 Suppl): 2455–63. <a target=xrefwindow id=d12713e872 href="http://www.ncbi.nlm.nih.gov/pubmed/23098785">PubMed Abstract </a> | <a target=xrefwindow id=d12713e875 href="http://dx.doi.org/10.1016/j.juro.2012.09.079">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717967661">F1000 Recommendation</a></span></li><li><a name=ref-14 class=n-a></a><span class=label>14. </span>&nbsp;<span class=citation><a name=d12713e888 class=n-a></a>Sussman DO: Overactive bladder: treatment options in primary care medicine. <i>J Am Osteopath Assoc.</i> 2007; <b>107</b>(9): 379–85. <a target=xrefwindow id=d12713e896 href="http://www.ncbi.nlm.nih.gov/pubmed/17908830">PubMed Abstract </a></span></li><li><a name=ref-15 class=n-a></a><span class=label>15. </span>&nbsp;<span class=citation><a name=d12713e905 class=n-a></a>Yamaguchi O, Uchida E, Higo N, <i> et al.</i>: Efficacy and safety of once-daily oxybutynin patch versus placebo and propiverine in Japanese patients with overactive bladder: A randomized double-blind trial. <i>Int J Urol.</i> 2014; <b>21</b>(6): 586–93. <a target=xrefwindow id=d12713e916 href="http://www.ncbi.nlm.nih.gov/pubmed/24350662">PubMed Abstract </a> | <a target=xrefwindow id=d12713e919 href="http://dx.doi.org/10.1111/iju.12372">Publisher Full Text </a></span></li><li><a name=ref-16 class=n-a></a><span class=label>16. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718146809"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e928 class=n-a></a>Goldfischer ER, Sand PK, Thomas H, <i> et al.</i>: Efficacy and safety of oxybutynin topical gel 3% in patients with urgency and/or mixed urinary incontinence: a randomized, double-blind, placebo-controlled study. <i>Neurourol Urodyn.</i> 2015; <b>34</b>(1): 37–43. <a target=xrefwindow id=d12713e939 href="http://www.ncbi.nlm.nih.gov/pubmed/24133005">PubMed Abstract </a> | <a target=xrefwindow id=d12713e942 href="http://dx.doi.org/10.1002/nau.22504">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718146809">F1000 Recommendation</a></span></li><li><a name=ref-17 class=n-a></a><span class=label>17. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725509613"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e955 class=n-a></a>Reynolds WS, McPheeters M, Blume J, <i> et al.</i>: Comparative Effectiveness of Anticholinergic Therapy for Overactive Bladder in Women: A Systematic Review and Meta-analysis. <i>Obstet Gynecol.</i> 2015; <b>125</b>(6): 1423–32. <a target=xrefwindow id=d12713e966 href="http://www.ncbi.nlm.nih.gov/pubmed/26000514">PubMed Abstract </a> | <a target=xrefwindow id=d12713e969 href="http://dx.doi.org/10.1097/AOG.0000000000000851">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725509613">F1000 Recommendation</a></span></li><li><a name=ref-18 class=n-a></a><span class=label>18. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725335338"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e983 class=n-a></a>Gray SL, Anderson ML, Dublin S, <i> et al.</i>: Cumulative use of strong anticholinergics and incident dementia: a prospective cohort study. <i>JAMA Intern Med.</i> 2015; <b>175</b>(3): 401–7. <a target=xrefwindow id=d12713e994 href="http://www.ncbi.nlm.nih.gov/pubmed/25621434">PubMed Abstract </a> | <a target=xrefwindow id=d12713e997 href="http://dx.doi.org/10.1001/jamainternmed.2014.7663">Publisher Full Text </a> | <a target=xrefwindow id=d12713e1001 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4358759">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725335338">F1000 Recommendation</a></span></li><li><a name=ref-19 class=n-a></a><span class=label>19. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727480843"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1014 class=n-a></a>Chung SD, Weng SS, Huang CY, <i> et al.</i>: Antimuscarinic Use in Females With Overactive Bladder Syndrome Increases the Risk of Depressive Disorder: A 3-Year Follow-up Study. <i>J Clin Pharmacol.</i> 2017; <b>57</b>(8): 1064–70. <a target=xrefwindow id=d12713e1025 href="http://www.ncbi.nlm.nih.gov/pubmed/28378881">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1028 href="http://dx.doi.org/10.1002/jcph.890">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727480843">F1000 Recommendation</a></span></li><li><a name=ref-20 class=n-a></a><span class=label>20. </span>&nbsp;<span class=citation><a name=d12713e1041 class=n-a></a>Chu FM, Dmochowski RR, Lama DJ, <i> et al.</i>: Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. <i>Am J Obstet Gynecol.</i> 2005; <b>192</b>(6): 1849–54; discussion 1854–5. <a target=xrefwindow id=d12713e1052 href="http://www.ncbi.nlm.nih.gov/pubmed/15970828">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1055 href="http://dx.doi.org/10.1016/j.ajog.2005.03.036">Publisher Full Text </a></span></li><li><a name=ref-21 class=n-a></a><span class=label>21. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726089367"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1064 class=n-a></a>Wehling M, Burkhardt H, Kuhn-Thiel A, <i> et al.</i>: VALFORTA: a randomised trial to validate the FORTA (Fit fOR The Aged) classification. <i>Age Ageing.</i> 2016; <b>45</b>(2): 262–7. <a target=xrefwindow id=d12713e1075 href="http://www.ncbi.nlm.nih.gov/pubmed/26786346">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1078 href="http://dx.doi.org/10.1093/ageing/afv200">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726089367">F1000 Recommendation</a></span></li><li><a name=ref-22 class=n-a></a><span class=label>22. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725854188"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1091 class=n-a></a>Chang SJ, Van Laecke E, Bauer SB, <i> et al.</i>: Treatment of daytime urinary incontinence: A standardization document from the International Children's Continence Society. <i>Neurourol Urodyn.</i> 2017; <b>36</b>(1): 43–50. <a target=xrefwindow id=d12713e1102 href="http://www.ncbi.nlm.nih.gov/pubmed/26473630">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1105 href="http://dx.doi.org/10.1002/nau.22911">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725854188">F1000 Recommendation</a></span></li><li><a name=ref-23 class=n-a></a><span class=label>23. </span>&nbsp;<span class=citation><a name=d12713e1118 class=n-a></a>Takahashi S, Takei M, Nishizawa O, <i> et al.</i>: Clinical Guideline for Female Lower Urinary Tract Symptoms. <i>Low Urin Tract Symptoms.</i> 2016; <b>8</b>(1): 5–29. <a target=xrefwindow id=d12713e1129 href="http://www.ncbi.nlm.nih.gov/pubmed/26789539">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1132 href="http://dx.doi.org/10.1111/luts.12111">Publisher Full Text </a></span></li><li><a name=ref-24 class=n-a></a><span class=label>24. </span>&nbsp;<span class=citation><a name=d12713e1142 class=n-a></a>Alloussi S, Mürtz G, Braun R, <i> et al.</i>: Efficacy, tolerability and safety of propiverine hydrochloride in comparison to oxybutynin in children with urge incontinence due to overactive bladder: Results of a multicentre observational cohort study. <i>BJU Int.</i> 2010; <b>106</b>(4): 550–6. <a target=xrefwindow id=d12713e1153 href="http://www.ncbi.nlm.nih.gov/pubmed/20002668">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1156 href="http://dx.doi.org/10.1111/j.1464-410X.2009.09129.x">Publisher Full Text </a></span></li><li><a name=ref-25 class=n-a></a><span class=label>25. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/1161858"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1165 class=n-a></a>Marschall-Kehrel D, Feustel C, Persson de Geeter C, <i> et al.</i>: Treatment with propiverine in children suffering from nonneurogenic overactive bladder and urinary incontinence: results of a randomized placebo-controlled phase 3 clinical trial. <i>Eur Urol.</i> 2009; <b>55</b>(3): 729–36. <a target=xrefwindow id=d12713e1176 href="http://www.ncbi.nlm.nih.gov/pubmed/18502028">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1179 href="http://dx.doi.org/10.1016/j.eururo.2008.04.062">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/1161858">F1000 Recommendation</a></span></li><li><a name=ref-26 class=n-a></a><span class=label>26. </span>&nbsp;<span class=citation><a name=d12713e1192 class=n-a></a>Lopez Pereira P, Miguelez C, Caffarati J, <i> et al.</i>: Trospium chloride for the treatment of detrusor instability in children. <i>J Urol.</i> 2003; <b>170</b>(5): 1978–81. <a target=xrefwindow id=d12713e1203 href="http://www.ncbi.nlm.nih.gov/pubmed/14532838">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1206 href="http://dx.doi.org/10.1097/01.ju.0000085667.05190.ad">Publisher Full Text </a></span></li><li><a name=ref-27 class=n-a></a><span class=label>27. </span>&nbsp;<span class=citation><a name=d12713e1215 class=n-a></a>Gleason JM, Daniels C, Williams K, <i> et al.</i>: Single center experience with oxybutynin transdermal system (patch) for management of symptoms related to non-neuropathic overactive bladder in children: an attractive, well tolerated alternative form of administration. <i>J Pediatr Urol.</i> 2014; <b>10</b>(4): 753–7. <a target=xrefwindow id=d12713e1226 href="http://www.ncbi.nlm.nih.gov/pubmed/24477421">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1229 href="http://dx.doi.org/10.1016/j.jpurol.2013.12.017">Publisher Full Text </a></span></li><li><a name=ref-28 class=n-a></a><span class=label>28. </span>&nbsp;<span class=citation><a name=d12713e1238 class=n-a></a>Nadeau G, Schröder A, Moore K, <i> et al.</i>: Double anticholinergic therapy for refractory neurogenic and nonneurogenic detrusor overactivity in children: Long-term results of a prospective open-label study. <i>Can Urol Assoc J.</i> 2014; <b>8</b>(5–6): 175–80. <a target=xrefwindow id=d12713e1249 href="http://www.ncbi.nlm.nih.gov/pubmed/25024786">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1252 href="http://dx.doi.org/10.5489/cuaj.1362">Publisher Full Text </a> | <a target=xrefwindow id=d12713e1256 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4081246">Free Full Text </a></span></li><li><a name=ref-29 class=n-a></a><span class=label>29. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726790146"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1265 class=n-a></a>Newgreen D, Bosman B, Hollestein-Havelaar A, <i> et al.</i>: Solifenacin in Children and Adolescents with Overactive Bladder: Results of a Phase 3 Randomised Clinical Trial. <i>Eur Urol.</i> 2017; <b>71</b>(3): 483–90. <a target=xrefwindow id=d12713e1276 href="http://www.ncbi.nlm.nih.gov/pubmed/27687820">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1279 href="http://dx.doi.org/10.1016/j.eururo.2016.08.061">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726790146">F1000 Recommendation</a></span></li><li><a name=ref-30 class=n-a></a><span class=label>30. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727617845"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1293 class=n-a></a>Newgreen D, Bosman B, Hollestein-Havelaar A, <i> et al.</i>: Long-Term Safety and Efficacy of Solifenacin in Children and Adolescents with Overactive Bladder. <i>J Urol.</i> 2017; <b>198</b>(4): 928–36. <a target=xrefwindow id=d12713e1304 href="http://www.ncbi.nlm.nih.gov/pubmed/28506854">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1307 href="http://dx.doi.org/10.1016/j.juro.2017.05.038">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727617845">F1000 Recommendation</a></span></li><li><a name=ref-31 class=n-a></a><span class=label>31. </span>&nbsp;<span class=citation><a name=d12713e1320 class=n-a></a>Gras J: Mirabegron for the treatment of overactive bladder. <i>Drugs Today (Barc).</i> 2012; <b>48</b>(1): 25–32. <a target=xrefwindow id=d12713e1328 href="http://www.ncbi.nlm.nih.gov/pubmed/22384458">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1331 href="http://dx.doi.org/10.1358/dot.2012.48.1.1738056">Publisher Full Text </a></span></li><li><a name=ref-32 class=n-a></a><span class=label>32. </span>&nbsp;<span class=citation><a name=d12713e1340 class=n-a></a>Sacco E, Bientinesi R, Tienforti D, <i> et al.</i>: Discovery history and clinical development of mirabegron for the treatment of overactive bladder and urinary incontinence. <i>Expert Opin Drug Discov.</i> 2014; <b>9</b>(4): 433–48. <a target=xrefwindow id=d12713e1351 href="http://www.ncbi.nlm.nih.gov/pubmed/24559030">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1354 href="http://dx.doi.org/10.1517/17460441.2014.892923">Publisher Full Text </a></span></li><li><a name=ref-33 class=n-a></a><span class=label>33. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725872979"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1363 class=n-a></a>Alexandre EC, Kiguti LR, Calmasini FB, <i> et al.</i>: Mirabegron relaxes urethral smooth muscle by a dual mechanism involving β<sub>3</sub>-adrenoceptor activation and α<sub>1</sub>-adrenoceptor blockade. <i>Br J Pharmacol.</i> 2016; <b>173</b>(3): 415–28. <a target=xrefwindow id=d12713e1381 href="http://www.ncbi.nlm.nih.gov/pubmed/26493129">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1384 href="http://dx.doi.org/10.1111/bph.13367">Publisher Full Text </a> | <a target=xrefwindow id=d12713e1387 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4728418">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725872979">F1000 Recommendation</a></span></li><li><a name=ref-34 class=n-a></a><span class=label>34. </span>&nbsp;<span class=citation><a name=d12713e1400 class=n-a></a>Andersson KE: Pharmacology: On the mode of action of mirabegron. <i>Nat Rev Urol.</i> 2016; <b>13</b>(3): 131–2. <a target=xrefwindow id=d12713e1408 href="http://www.ncbi.nlm.nih.gov/pubmed/26666361">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1411 href="http://dx.doi.org/10.1038/nrurol.2015.297">Publisher Full Text </a></span></li><li><a name=ref-35 class=n-a></a><span class=label>35. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718302556"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1420 class=n-a></a>Rossanese M, Novara G, Challacombe B, <i> et al.</i>: Critical analysis of phase II and III randomised control trials (RCTs) evaluating efficacy and tolerability of a β<sub>3</sub>-adrenoceptor agonist (Mirabegron) for overactive bladder (OAB). <i>BJU Int.</i> 2015; <b>115</b>(1): 32–40. <a target=xrefwindow id=d12713e1434 href="http://www.ncbi.nlm.nih.gov/pubmed/24602031">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1438 href="http://dx.doi.org/10.1111/bju.12730">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718302556">F1000 Recommendation</a></span></li><li><a name=ref-36 class=n-a></a><span class=label>36. </span>&nbsp;<span class=citation><a name=d12713e1452 class=n-a></a>Chapple CR, Kaplan SA, Mitcheson D, <i> et al.</i>: Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year. <i>Int J Urol.</i> 2014; <b>21</b>(10): 960–7. <a target=xrefwindow id=d12713e1463 href="http://www.ncbi.nlm.nih.gov/pubmed/25092441">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1466 href="http://dx.doi.org/10.1111/iju.12568">Publisher Full Text </a></span></li><li><a name=ref-37 class=n-a></a><span class=label>37. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718520609"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1475 class=n-a></a>Chapple C, Khullar V, Nitti VW, <i> et al.</i>: Efficacy of the β3-adrenoceptor agonist mirabegron for the treatment of overactive bladder by severity of incontinence at baseline: a post hoc analysis of pooled data from three randomised phase 3 trials. <i>Eur Urol.</i> 2015; <b>67</b>(1): 11–4. <a target=xrefwindow id=d12713e1486 href="http://www.ncbi.nlm.nih.gov/pubmed/25092537">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1489 href="http://dx.doi.org/10.1016/j.eururo.2014.06.052">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718520609">F1000 Recommendation</a></span></li><li><a name=ref-38 class=n-a></a><span class=label>38. </span>&nbsp;<span class=citation><a name=d12713e1502 class=n-a></a>Robinson D, Thiagamoorthy G, Cardozo L: A drug safety evaluation of mirabegron in the management of overactive bladder. <i>Expert Opin Drug Saf.</i> 2016; <b>15</b>(5): 689–96. <a target=xrefwindow id=d12713e1510 href="http://www.ncbi.nlm.nih.gov/pubmed/26980445">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1513 href="http://dx.doi.org/10.1517/14740338.2016.1165663">Publisher Full Text </a></span></li><li><a name=ref-39 class=n-a></a><span class=label>39. </span>&nbsp;<span class=citation><a name=d12713e1522 class=n-a></a>Maman K, Aballea S, Nazir J, <i> et al.</i>: Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. <i>Eur Urol.</i> 2014; <b>65</b>(4): 755–65. <a target=xrefwindow id=d12713e1533 href="http://www.ncbi.nlm.nih.gov/pubmed/24275310">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1536 href="http://dx.doi.org/10.1016/j.eururo.2013.11.010">Publisher Full Text </a></span></li><li><a name=ref-40 class=n-a></a><span class=label>40. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/732289310"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1545 class=n-a></a>Yamaguchi O, Ikeda Y, Ohkawa S: Phase III Study to Assess Long-Term (52-Week) Safety and Efficacy of Mirabegron, a β<sub>3</sub> -Adrenoceptor Agonist, in Japanese Patients with Overactive Bladder. <i>Low Urin Tract Symptoms.</i> 2017; <b>9</b>(1): 38–45. <a target=xrefwindow id=d12713e1556 href="http://www.ncbi.nlm.nih.gov/pubmed/28120446">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1559 href="http://dx.doi.org/10.1111/luts.12107">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/732289310">F1000 Recommendation</a></span></li><li><a name=ref-41 class=n-a></a><span class=label>41. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726148399"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1572 class=n-a></a>Blais AS, Nadeau G, Moore K, <i> et al.</i>: Prospective Pilot Study of Mirabegron in Pediatric Patients with Overactive Bladder. <i>Eur Urol.</i> 2016; <b>70</b>(1): 9–13. <a target=xrefwindow id=d12713e1583 href="http://www.ncbi.nlm.nih.gov/pubmed/26876327">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1586 href="http://dx.doi.org/10.1016/j.eururo.2016.02.007">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726148399">F1000 Recommendation</a></span></li><li><a name=ref-42 class=n-a></a><span class=label>42. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727069303"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1600 class=n-a></a>Morin F, Blais AS, Nadeau G, <i> et al.</i>: Dual Therapy for Refractory Overactive Bladder in Children: A Prospective Open-Label Study. <i>J Urol.</i> 2017; <b>197</b>(4): 1158–63. <a target=xrefwindow id=d12713e1611 href="http://www.ncbi.nlm.nih.gov/pubmed/27914999">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1614 href="http://dx.doi.org/10.1016/j.juro.2016.11.101">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727069303">F1000 Recommendation</a></span></li><li><a name=ref-43 class=n-a></a><span class=label>43. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/718339612"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1627 class=n-a></a>Abrams P, Kelleher C, Staskin D, <i> et al.</i>: Combination treatment with mirabegron and solifenacin in patients with overactive bladder: efficacy and safety results from a randomised, double-blind, dose-ranging, phase 2 study (Symphony). <i>Eur Urol.</i> 2015; <b>67</b>(3): 577–88. <a target=xrefwindow id=d12713e1638 href="http://www.ncbi.nlm.nih.gov/pubmed/24612659">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1641 href="http://dx.doi.org/10.1016/j.eururo.2014.02.012">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/718339612">F1000 Recommendation</a></span></li><li><a name=ref-44 class=n-a></a><span class=label>44. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/726641973"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1654 class=n-a></a>Abrams P, Kelleher C, Staskin D, <i> et al.</i>: Combination treatment with mirabegron and solifenacin in patients with overactive bladder: exploratory responder analyses of efficacy and evaluation of patient-reported outcomes from a randomized, double-blind, factorial, dose-ranging, Phase II study (SYMPHONY). <i>World J Urol.</i> 2017; <b>35</b>(5): 827–38. <a target=xrefwindow id=d12713e1665 href="http://www.ncbi.nlm.nih.gov/pubmed/27514371">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1668 href="http://dx.doi.org/10.1007/s00345-016-1908-1">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/726641973">F1000 Recommendation</a></span></li><li><a name=ref-45 class=n-a></a><span class=label>45. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/727521501"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1681 class=n-a></a>Herschorn S, Chapple CR, Abrams P, <i> et al.</i>: Efficacy and safety of combinations of mirabegron and solifenacin compared with monotherapy and placebo in patients with overactive bladder (SYNERGY study). <i>BJU Int.</i> 2017; <b>120</b>(4): 562–575. <a target=xrefwindow id=d12713e1692 href="http://www.ncbi.nlm.nih.gov/pubmed/28418102">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1695 href="http://dx.doi.org/10.1111/bju.13882">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/727521501">F1000 Recommendation</a></span></li><li><a name=ref-46 class=n-a></a><span class=label>46. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725336183"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1708 class=n-a></a>Yamaguchi O, Kakizaki H, Homma Y, <i> et al.</i>: Safety and efficacy of mirabegron as ‘add-on’ therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study). <i>BJU Int.</i> 2015; <b>116</b>(4): 612–22. <a target=xrefwindow id=d12713e1719 href="http://www.ncbi.nlm.nih.gov/pubmed/25639296">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1722 href="http://dx.doi.org/10.1111/bju.13068">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725336183">F1000 Recommendation</a></span></li><li><a name=ref-47 class=n-a></a><span class=label>47. </span>&nbsp;<span class=citation><a name=d12713e1735 class=n-a></a>Hedlund P, Gratzke C: The endocannabinoid system - a target for the treatment of LUTS? <i>Nat Rev Urol.</i> 2016; <b>13</b>(8): 463–70. <a target=xrefwindow id=d12713e1743 href="http://www.ncbi.nlm.nih.gov/pubmed/27377161">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1746 href="http://dx.doi.org/10.1038/nrurol.2016.110">Publisher Full Text </a></span></li><li><a name=ref-48 class=n-a></a><span class=label>48. </span>&nbsp;<span class=citation><a name=d12713e1756 class=n-a></a>Mallet C, Dubray C, Dualé C: FAAH inhibitors in the limelight, but regrettably. <i>Int J Clin Pharmacol Ther.</i> 2016; <b>54</b>(7): 498–501. <a target=xrefwindow id=d12713e1764 href="http://www.ncbi.nlm.nih.gov/pubmed/27191771">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1767 href="http://dx.doi.org/10.5414/CP202687">Publisher Full Text </a> | <a target=xrefwindow id=d12713e1770 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4941643">Free Full Text </a></span></li><li><a name=ref-49 class=n-a></a><span class=label>49. </span>&nbsp;<span class=citation><a name=d12713e1779 class=n-a></a>Bettez M, Le Tu M, Carlson K, <i> et al.</i>: 2012 update: guidelines for adult urinary incontinence collaborative consensus document for the canadian urological association. <i>Can Urol Assoc J.</i> 2012; <b>6</b>(5): 354–63. <a target=xrefwindow id=d12713e1790 href="http://www.ncbi.nlm.nih.gov/pubmed/23093627">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1793 href="http://www.ncbi.nlm.nih.gov/pmc/articles/3478335">Free Full Text </a></span></li><li><a name=ref-50 class=n-a></a><span class=label>50. </span>&nbsp;<span class=citation><a name=d12713e1802 class=n-a></a>Gormley EA, Lightner DJ, Faraday M, <i> et al.</i>: Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline amendment. <i>J Urol.</i> 2015; <b>193</b>(5): 1572–80. <a target=xrefwindow id=d12713e1813 href="http://www.ncbi.nlm.nih.gov/pubmed/25623739">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1816 href="http://dx.doi.org/10.1016/j.juro.2015.01.087">Publisher Full Text </a></span></li><li><a name=ref-51 class=n-a></a><span class=label>51. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725235156"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1825 class=n-a></a>Rahn DD, Ward RM, Sanses TV, <i> et al.</i>: Vaginal estrogen use in postmenopausal women with pelvic floor disorders: systematic review and practice guidelines. <i>Int Urogynecol J.</i> 2015; <b>26</b>(1): 3–13. <a target=xrefwindow id=d12713e1836 href="http://www.ncbi.nlm.nih.gov/pubmed/25392183">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1839 href="http://dx.doi.org/10.1007/s00192-014-2554-z">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725235156">F1000 Recommendation</a></span></li><li><a name=ref-52 class=n-a></a><span class=label>52. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/725796938"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1852 class=n-a></a>Weber MA, Kleijn MH, Langendam M, <i> et al.</i>: Local Oestrogen for Pelvic Floor Disorders: A Systematic Review. <i>PLoS One.</i> 2015; <b>10</b>(9):e0136265. <a target=xrefwindow id=d12713e1863 href="http://www.ncbi.nlm.nih.gov/pubmed/26383760">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1866 href="http://dx.doi.org/10.1371/journal.pone.0136265">Publisher Full Text </a> | <a target=xrefwindow id=d12713e1870 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4575150 ">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/725796938">F1000 Recommendation</a></span></li><li><a name=ref-53 class=n-a></a><span class=label>53. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="https://f1000.com/prime/717962271"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e1883 class=n-a></a>Cody JD, Jacobs ML, Richardson K, <i> et al.</i>: Oestrogen therapy for urinary incontinence in post-menopausal women. <i>Cochrane Database Syst Rev.</i> 2012; <b>10</b>: CD001405. <a target=xrefwindow id=d12713e1894 href="http://www.ncbi.nlm.nih.gov/pubmed/23076892">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1897 href="http://dx.doi.org/10.1002/14651858.CD001405.pub3">Publisher Full Text </a> | <a target=_blank title="F1000 recommended" href="https://f1000.com/prime/717962271">F1000 Recommendation</a></span></li><li><a name=ref-54 class=n-a></a><span class=label>54. </span>&nbsp;<span class=citation><a name=d12713e1911 class=n-a></a>Drake MJ, Morris N, Apostolidis A, <i> et al.</i>: The urinary microbiome and its contribution to lower urinary tract symptoms; ICI-RS 2015. <i>Neurourol Urodyn.</i> 2017; <b>36</b>(4): 850–3. <a target=xrefwindow id=d12713e1922 href="http://www.ncbi.nlm.nih.gov/pubmed/28444712">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1925 href="http://dx.doi.org/10.1002/nau.23006">Publisher Full Text </a></span></li><li><a name=ref-55 class=n-a></a><span class=label>55. </span>&nbsp;<span class=citation><a name=d12713e1934 class=n-a></a>Brubaker L, Nager CW, Richter HE, <i> et al.</i>: Urinary bacteria in adult women with urgency urinary incontinence. <i>Int Urogynecol J.</i> 2014; <b>25</b>(9): 1179–84. <a target=xrefwindow id=d12713e1945 href="http://www.ncbi.nlm.nih.gov/pubmed/24515544">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1948 href="http://dx.doi.org/10.1007/s00192-013-2325-2">Publisher Full Text </a> | <a target=xrefwindow id=d12713e1952 href="http://www.ncbi.nlm.nih.gov/pmc/articles/4128900">Free Full Text </a></span></li><li><a name=ref-56 class=n-a></a><span class=label>56. </span>&nbsp;<span class=citation><a name=d12713e1961 class=n-a></a>National Collaborating Centre for Women’s and Children’s Health (UK): Urinary Incontinence: The Management of Urinary Incontinence in Women. (RCOG Press National Collaborating Centre for Women's and Children's Health). 2006. <a target=xrefwindow id=d12713e1963 href="http://www.ncbi.nlm.nih.gov/pubmed/21938861">PubMed Abstract </a></span></li><li><a name=ref-57 class=n-a></a><span class=label>57. </span>&nbsp;<span class=citation><a name=d12713e1972 class=n-a></a>Norton PA, Zinner NR, Yalcin I, <i> et al.</i>: Duloxetine versus placebo in the treatment of stress urinary incontinence. <i>Am J Obstet Gynecol.</i> 2002; <b>187</b>(1): 40–8. <a target=xrefwindow id=d12713e1983 href="http://www.ncbi.nlm.nih.gov/pubmed/12114886">PubMed Abstract </a> | <a target=xrefwindow id=d12713e1986 href="http://dx.doi.org/10.1067/mob.2002.124840">Publisher Full Text </a></span></li><li><a name=ref-58 class=n-a></a><span class=label>58. </span>&nbsp;<span class=citation><a name=d12713e1995 class=n-a></a>Dmochowski RR, Miklos JR, Norton PA, <i> et al.</i>: Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence. <i>J Urol.</i> 2003; <b>170</b>(4 pt 1): 1259–63. <a target=xrefwindow id=d12713e2006 href="http://www.ncbi.nlm.nih.gov/pubmed/14501737">PubMed Abstract </a> | <a target=xrefwindow id=d12713e2009 href="http://dx.doi.org/10.1097/01.ju.0000080708.87092.cc">Publisher Full Text </a></span></li><li><a name=ref-59 class=n-a></a><span class=label>59. </span>&nbsp;<span class=citation><a target=_blank title="F1000 recommended" class="research-layout prime-recommended-reference" href="http://f1000.com/prime/732289316"><span class="f1r-icon icon-79_faculty_recommended_badge small red vmiddle"></span></a><a name=d12713e2018 class=n-a></a>Maund E, Guski LS, Gøtzsche PC: Considering benefits and harms of duloxetine for treatment of stress urinary incontinence: a meta-analysis of clinical study reports. <i>CMAJ.</i> 2017; <b>189</b>(5): E194–E203. <a target=xrefwindow id=d12713e2026 href="http://www.ncbi.nlm.nih.gov/pubmed/28246265">PubMed Abstract </a> | <a target=xrefwindow id=d12713e2029 href="http://dx.doi.org/10.1503/cmaj.151104">Publisher Full Text </a> | <a target=xrefwindow id=d12713e2032 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5289870">Free Full Text </a> | <a target=_blank title="F1000 recommended" href="http://f1000.com/prime/732289316">F1000 Recommendation</a></span></li><li><a name=ref-60 class=n-a></a><span class=label>60. </span>&nbsp;<span class=citation><a name=d12713e2046 class=n-a></a>Wieseler B, McGauran N: Secrecy or transparency? The future of regulatory trial data. <i>CMAJ.</i> 2017; <b>189</b>(5): E185–E186. <a target=xrefwindow id=d12713e2054 href="http://www.ncbi.nlm.nih.gov/pubmed/28246263">PubMed Abstract </a> | <a target=xrefwindow id=d12713e2057 href="http://dx.doi.org/10.1503/cmaj.161088">Publisher Full Text </a> | <a target=xrefwindow id=d12713e2060 href="http://www.ncbi.nlm.nih.gov/pmc/articles/5289868">Free Full Text </a></span></li><li><a name=ref-61 class=n-a></a><span class=label>61. </span>&nbsp;<span class=citation><a name=d12713e2069 class=n-a></a>Smith A, Bevan D, Douglas HR, <i> et al.</i>: Management of urinary incontinence in women: summary of updated NICE guidance. <i>BMJ.</i> 2013; <b>347</b>: f5170. <a target=xrefwindow id=d12713e2080 href="http://www.ncbi.nlm.nih.gov/pubmed/24021756">PubMed Abstract </a> | <a target=xrefwindow id=d12713e2083 href="http://dx.doi.org/10.1136/bmj.f5170">Publisher Full Text </a></span></li></ul></div></div></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 19 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2148/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2148/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> <div class="f1r-article-mobile margin-bottom-30"> <div class=contracted-details> <a href="#" class="contracted-details-label author-affiliations"><span class=contracted></span>Author details</a> <a href="#" class=section-title>Author details</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details affiliations is-hidden"> <sup>1</sup> Department of Medicine, University of Pittsburgh School of Medicine, A 1217 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA<br/> <sup>2</sup> Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, A 1217 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA, 15261, USA<br/> <p> <div class=margin-bottom> Bronagh McDonnell <br/> <span>Roles: </span> Investigation, Writing – Original Draft Preparation </div> <div class=margin-bottom> Lori Ann Birder <br/> <span>Roles: </span> Conceptualization, Supervision, Writing – Review & Editing </div> </p> </div> </div> <div class=contracted-details> <a href="#" class=section-title>Article Versions (1)</a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> <div> <a href="https://f1000research.com/articles/6-2148/v1" title="Open version 1 of this article." class="" gahelper=1>version 1</a> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div> Published: 19 Dec 2017, 6:2148 </div> <div class=""><a href="https://doi.org/10.12688/f1000research.12593.1">https://doi.org/10.12688/f1000research.12593.1</a></div> </div> </div> <div class=contracted-details> <a href="#" class=section-title> <span class="f1r-icon icon-100_open_access"></span> Copyright </a> <span class="f1r-icon icon-14_more_small section-control"></span> <span class="f1r-icon icon-10_less_small section-control"></span> <div class="expanded-details grant-information article-page is-hidden"> © 2017 McDonnell B and Birder LA. This is an open access article distributed under the terms of the <a href="http://creativecommons.org/licenses/by/4.0/" target=_blank data-test-id=box-licence-link>Creative Commons Attribution License</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. </div> </div> <div class="padding-top-30 research-layout"> <div class=article-toolbox-wrapper-mobile> <div class=article-tools-icon-mobile data-section=download> <span class="f1r-icon icon-76_download_file white"></span> </div> <div class="article-tools-icon-mobile mobile-metrics article-metrics-wrapper metrics-icon-wrapper" data-section=metrics data-version-id=13637 data-id=12593 data-downloads="" data-views="" data-scholar="10.12688/f1000research.12593.1" data-recommended="" data-f1r-ga-helper="Article Page Metrics (Mobile)"> <span class="f1r-icon icon-89_metrics white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=cite> <span class="f1r-icon icon-82_quote white"></span> </div> <div class="article-tools-icon-mobile " data-section=track> <span class="f1r-icon icon-90_track white"></span> </div> <div class=article-tools-divider-mobile></div> <div class=article-tools-icon-mobile data-section=share> <span class="f1r-icon icon-34_share white"></span> </div> <span class=article-toolbox-stretch></span> </div> <div class=article-toolbox-content-mobile> <div class="toolbox-section download"> <div class=toolbox-section-heading>Download</div> <div class=toolbox-section-content> <a href="https://f1000research.com/articles/6-2148/v1/pdf?article_uuid=66907a2d-9c15-4477-be93-6478f65d8fc4" title="Download PDF" class="no-decoration pdf-download-helper"> <span class="f1r-icon icon-102_download_pdf toolbox-section-icon"></span> </a> <div class=toolbox-section-option-divider>&nbsp;</div> <a id=mobile-download-xml class=no-decoration href="#" title="Download XML"> <span class="f1r-icon icon-103_download_xml toolbox-section-icon"></span> </a> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>Export To</div> <div class=toolbox-section-content> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=WORKSPACE>Sciwheel</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=BIBTEX>Bibtex</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=ENDNOTE>EndNote</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=PROCITE>ProCite</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=REF_MANAGER>Ref. Manager (RIS)</button> <button class="primary no-fill orange-text-and-border mobile-export" data-etype=SENTE>Sente</button> </div> </div> <div class="toolbox-section metrics"> <div class="toolbox-section-heading no-top-border">metrics</div> <div class="toolbox-section-divider toolbox-section-divider--no-height"></div> <div class=article-metrics-pageinfo> <div class=c-article-metrics-table> <table class=c-article-metrics-table__table> <thead> <tr> <th></th> <th><span class=c-article-metrics-table__heading>Views</span></th> <th><span class=c-article-metrics-table__heading>Downloads</span></th> </tr> </thead> <tbody> <tr> <th class=c-article-metrics-table__row-heading><span class="c-article-metrics-table__platform u-platform--" data-test-id=metrics_platform_name_mob>F1000Research</span></th> <td class="c-article-metrics-table__value js-article-views-count" data-test-id=metrics_platform_views_mob>-</td> <td class="c-article-metrics-table__value js-article-downloads-count" data-test-id=metrics_platform_downloads_mob>-</td> </tr> <tr> <th class=c-article-metrics-table__row-heading> <span class="u-ib u-middle c-article-metrics-table__pmc" data-test-id=metrics_pmc_name_mob>PubMed Central</span> <div class="c-block-tip c-block-tip--centered c-article-metrics-table__tooltip c-block-tip--md-padding c-block-tip--small-arrow u-ib u-middle"> <button type=button class="u-black--medium u-black--high@hover u-ib u-middle c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content>Data from PMC are received and updated monthly.</div> </div> </th> <td class="c-article-metrics-table__value js-pmc-views-count" data-test-id=metrics_pmc_views_mob>-</td> <td class="c-article-metrics-table__value js-pmc-downloads-count" data-test-id=metrics_pmc_downloads_mob>-</td> </tr> </tbody> </table> </div> </div> <span class=metrics-citations-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-heading u-mb--1">Citations</div> <div> <div class=toolbox-section-colsplit> <div class=citations-scopus-logo> <a href="" target=_blank class="is-hidden metrics-citation-icon" title="View full citation details at www.scopus.com"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count scopus"> <a href='' class='scopus-citation-link is-hidden' target=_blank title='View full citation details at www.scopus.com'>0</a> </div> </div> <div class=toolbox-section-colsplit> <div class="citations-pubmed-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon f1000research" title="View full citation details"><i class="material-icons scopus-icon">open_in_new</i></a> </div> <div class="toolbox-section-count pubmed"> <a href='' class='pubmed-citation-link is-hidden' target=_blank title='View full citation details'>0</a> </div> </div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <div class="citations-scholar-logo f1000research"> <a href="" target=_blank class="is-hidden metrics-citation-icon google-scholar f1000research" title="View full citation details" data-scholar="10.12688/f1000research.12593.1"><i class="material-icons scopus-icon">open_in_new</i></a> </div> </div> </div> </span> <span class=metrics-details-container> <div class=toolbox-section-divider></div> <div class="toolbox-section-content altmetric-section"> <div class=altmetrics-image></div> <div class=altmetrics-more-link> <a href="" target=_blank class=f1r-standard-link>SEE MORE DETAILS</a> </div> <div class=altmetric-mobile-column-counts></div> <div class=altmetric-mobile-column-readers></div> <div class=toolbox-section-divider></div> </div> </span> </div> <div class="toolbox-section cite"> <div class="toolbox-section-heading no-top-border">CITE</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>how to cite this article</div> <div id=citation-copy-mobile class="toolbox-section-content text-content heading9 small" data-test-id=mob_copy-citation_text> McDonnell B and Birder LA. Recent advances in pharmacological management of urinary incontinence [version 1; peer review: 2 approved] <i>F1000Research</i> 2017, <b>6</b>(F1000 Faculty Rev):2148 (<a href="https://doi.org/10.12688/f1000research.12593.1" target=_blank>https://doi.org/10.12688/f1000research.12593.1</a>) </div> <div class=toolbox-section-divider></div> <div class="toolbox-section-content text-content heading9 small"> NOTE: <em>it is important to ensure the information in <b>square brackets after the title</b> is included in all citations of this article.</em> </div> <div class=toolbox-section-content> <button class="primary orange extra-padding copy-cite-article-mobile js-clipboard" data-clipboard-target="#citation-copy-mobile" title="Copy the current citation details." data-test-id=mob_copy-citation_button-mob>COPY CITATION DETAILS</button> </div> </div> <div class="toolbox-section track"> <div class="toolbox-section-heading no-top-border">track</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-heading>receive updates on this article</div> <div class="toolbox-section-content padding-left-20 padding-right-20 heading9 small"> Track an article to receive email alerts on any updates to this article. </div> <div class=toolbox-section-content> <a data-article-id=12593 id=mobile-track-article-signin-12593 title="Receive updates on new activity such as publication of new versions, peer reviews or author responses." href="/login?originalPath=/trackArticle/12593?target=/articles/6-2148/v1"> <button class="primary orange extra-padding"> TRACK THIS ARTICLE </button> </a> </div> </div> <div class="toolbox-section share"> <div class="toolbox-section-heading no-top-border">Share</div> <div class=toolbox-section-divider></div> <div class=toolbox-section-content> <a target=_blank class="f1r-shares-icon-square f1r-shares-email" title="Email this article"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-twitter" title="Share on Twitter"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-facebook" title="Share on Facebook"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-linkedin" title="Share on LinkedIn"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-reddit" title="Share on Reddit"></a> <a target=_blank class="f1r-shares-icon-square f1r-shares-mendelay" title="Share on Mendeley"></a> <div class="email-article-wrapper email-article-version-container"> <div class=toolbox-section-divider></div> <script src='https://www.recaptcha.net/recaptcha/api.js'></script> <form class="recommend-version-form-mobile research-layout"> <p>All fields are required.</p> <input name=versionId type=hidden value=13637 /> <input name=articleId type=hidden value=12593 /> <input name=senderName class="form-input-field reg-form" value="" type=text placeholder="Your name"/> <input name=senderEmail class="form-input-field reg-form margin-top" value="" type=text placeholder="Your email address"/> <textarea name=recipientEmails class="form-textarea-field ninetynine-percent-wide margin-top no-resize" placeholder="Recipient email address(es) (comma delimited)"></textarea> <input class="form-input-field reg-form margin-top" name=subject type=text value="Interesting article on F1000Research" placeholder=Subject /> <textarea name=message class="form-textarea-field reg-form margin-top no-resize">I thought this article from F1000Research (https://f1000research.com) would be of interest to you.</textarea> <div class="g-recaptcha margin-top" data-sitekey=6LcHqxoUAAAAANP3_0TzpGG6qFvl4DhbUcuRzw7W></div> <input value="" name=captcha type=hidden /> <p>A full article citation will be automatically included.</p> <p><img class="ticker-email-article-details hidden" src="/img/ticker.gif" alt=loading /></p> <button class="secondary orange margin-bottom" data-test-id=version_share_email_send>SEND EMAIL</button> <div class="orange-message margin-bottom is-hidden" data-test-id=version_share_email_message></div> </form> </div> </div> </div> </div> </div> <a name=article-reports></a> <div id=article-reports class="u-mt--3 reports-comments no-divider"> <div class="current-referee-status current-referee-status--faculty "> <h2 class=main-title id=current-referee-status> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-85_peer_review size30"></span> </span> Open Peer Review <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> <a name=current-referee-status></a> <div class=current-referee-status__content name=add-new-report-comment id=add-new-report-comment> Current Reviewer Status: <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-desk-inline"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile float-right"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> </span> <span class="research-layout f1r-article-mobile"> <div class=mobile-ref-status-help> Key to Reviewer Statuses <span class=referee-status-pointer></span> <span class="view-control float-right">VIEW</span> <span class="view-control float-right is-hidden">HIDE</span> <div class=mobile-ref-status-help-content> <div class="cf margin-top"> <span class="f1r-icon icon-86_approved status-green smaller float-left margin-bottom-40 margin-right" title=Approved></span> <span class=title>Approved</span>The paper is scientifically sound in its current form and only minor, if any, improvements are suggested </div> <div class="cf margin-top"> <span class="f1r-icon icon-87_approved_reservations status-green smaller float-left margin-bottom-40 margin-right" title="Approved with Reservations"></span> <span class=title>Approved with reservations</span> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </div> <div class="cf margin-top"> <span class="f1r-icon icon-88_not_approved status-red small float-left margin-bottom-30 margin-right" title="Not Approved"></span> <span class=title>Not approved</span>Fundamental flaws in the paper seriously undermine the findings and conclusions </div> </div> </div> </span> <div class=editorial-note> <h5 class=editorial-note__title>Editorial Note on the Review Process</h5> <p class=editorial-note__text><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home">Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> </div> <div class=approved-referee> <h4 class=approved-referee__title>Reviewers who approved this article</h4> <ol class=approved-referee__list> <li class="approved-referee__list-item "> <span class=approved-referee__co-referee> <strong>St&eacute;phane Bolduc</strong>, Division of Urology, CHU de Québec-Université Laval, Canada </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> <li class="approved-referee__list-item margin-top-20"> <span class=approved-referee__co-referee> <strong>Linda Cardozo</strong>, Urogynaecology Department, King's College London, UK </span> <span class=approved-referee__competing-list> <strong>Competing interests:</strong> No competing interests were declared. (for version 1) <br> </span> </li> </ol> </div> </div> </div> </div> <div class="f1r-article-mobile research-layout"> <div class="mobile-sections-divider before-comments"></div> </div> <div id=article-comments class="article-comments padding-bottom-20"> <div class=current-article-comment-section> <h2 class=main-title name=add-new-comment id=add-new-comment> <span class="research-layout f1r-article-mobile-inline valign-middle"> <span class="f1r-icon icon-104_comments size30"></span> </span> <span class=f1r-article-desk-inline>Comments on this article</span> <span class=f1r-article-mobile-inline>Comments (0)</span> <span class="f1r-article-mobile-inline float-right"> <span class="f1r-icon icon-14_more_small"></span> <span class="f1r-icon icon-10_less_small"></span> </span> </h2> </div> <div class="f1r-article-desk-inline referee-report-info-box referee-report-version-box"> Version 1 </div> <div class="f1r-article-mobile research-layout mobile-version-info padding-top-30"> <span class=mversion>VERSION 1</span> <span class=details>PUBLISHED 19 Dec 2017</span> <span class="article-pubinfo-mobile versions-section"> </span> </div> <div class="f1r-article-mobile research-layout margin-top-20 is-centered"> <a href="/login?originalPath=/articles/6-2148/v1&scrollTo=add-new-comment" class=register-report-comment-button data-test-id=add-comment_mob> <button class="primary orange extra-padding comment-on-this-report">ADD YOUR COMMENT</button> </a> </div> <a href="/login?originalPath=/articles/6-2148/v1&scrollTo=add-new-comment" class="f1r-article-desk register-report-comment-button" data-test-id=add-comment> <span class=contracted></span>Comment </a> </div> </div> </div> <div id=article_main-column class="p-article__sidebar o-layout__item u-1/3 not-expanded js-article-sidebar"> <div class="o-tab p-article__column-toggle-container"> <button class="c-tab c-tab--left js-column-toggle p-article__column-toggle not-expanded " type=button data-target-main=article_main-column data-target-secondary=article_secondary-column><i class="c-tab__icon material-icons u-hide@expanded">keyboard_arrow_left</i><i class="c-tab__icon material-icons u-show@expanded">keyboard_arrow_right</i></button> </div> <div class=p-article__sidebar-content> <div class="p-article__sidebar-scroller js-article-sidebar-scroller"> <section class="p-article__sidebar-view js-article-sidebar-view js-article-sidebar-main u-pt u-pb--8" data-view=peer-review> <div class="o-layout o-layout--flush"> <div class="o-layout__item u-pl"> <h3 class="u-mt--0 u-mb--2 t-h3 u-weight--md u-pl" data-test-id=article_sidebar_heading>Open Peer Review</h3> </div> <div class=o-layout__item> <section class=""> <div class="p-article__sidebar-highlight u-mb--2 u-pr--1"> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md u-mr--1/2">Reviewer Status</h4> <div class="c-referee-status__icons u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=29035-29057></i> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=17235-29058></i> </div> </div> <div class="o-actions__secondary _mdl-layout"> <div class="c-block-tip p-article__sidebar-tooltip c-block-tip--below c-block-tip--small-arrow c-block-tip--sm-padding"> <button type=button class="c-button c-button--icon c-button--text c-block-tip__toggle"><i class="material-icons c-button--icon__icon">info_outline</i></button> <div class=c-block-tip__content> <p class="t-body u-mt--0 u-mb--0"><em class=u-weight--md>Alongside their report, reviewers assign a status to the article:</em></p> <dl class=c-definitions> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--approved " title=Approved #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved</span></dt> <dd class="c-definitions__description t-caption">The paper is scientifically sound in its current form and only minor, if any, improvements are suggested</dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--reservations" title="Approved with Reservations" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Approved with reservations</span></dt> <dd class="c-definitions__description t-caption"> A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </dd> <dt class="c-definitions__term u-upper t-control u-weight--md u-black--high"><span class="u-ib u-middle"> <i class="c-icn--f1r-icon c-icn--not-approved " title="Not Approved" #data-refInfo=""></i> </span> <span class="u-middle u-ib u-ml--1/2">Not approved</span></dt> <dd class="c-definitions__description t-caption">Fundamental flaws in the paper seriously undermine the findings and conclusions</dd> </dl> </div> </div> </div> </div> </div> <div class="o-layout__item u-mb--1"><h4 class="u-mt--0 u-mb--0 u-ib u-middle t-h4 u-weight--md">Reviewer Reports</h4></div> <table class="c-report-timeline u-mb--2"> <thead class=c-report-timeline__headings> <tr> <th></th> <th class="u-pb--1/2" colspan=2><em class="t-body u-weight--rg">Invited Reviewers</em></th> </tr> <tr class=c-report-timeline__headings-row> <th></th> <th class="c-report-timeline__headings-version p-article__color--dark">1</th> <th class="c-report-timeline__headings-version p-article__color--dark">2</th> </tr> </thead> <tbody> <tr class="c-report-timeline__row c-report-timeline__row--selected "> <th class=c-report-timeline__version> <a data-test-id=sidebar_timeline_v1_version href="https://f1000research.com/articles/6-2148/v1">Version 1</a><br/> <span class=p-article__color--dark> <span data-test-id=sidebar_timeline_v1_date class=c-report-timeline__date>19 Dec 17</span> </span> </th> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> <td class="c-report-timeline__report c-report-timeline__cell "> <i class="c-icn--f1r-icon c-icn--approved small" title=Approved #data-refInfo=""></i> </td> </tr> </tbody> </table> <div class=o-layout__item> <hr class="c-hr c-hr--low u-mb--2"> </div> </section> </div> <div class=o-layout__item> <div class="u-pl u-pr"> <p class="t-body u-mt--0 u-mb--2"><a href="/browse/faculty-reviews">Faculty Reviews</a> are review articles written by the prestigious Members of <a href="https://facultyopinions.com/prime/home" target=_blank class=in-text-link>Faculty Opinions</a>. The articles are commissioned and peer reviewed before publication to ensure that the final, published version is comprehensive and accessible. The reviewers who approved the final version are listed with their names and affiliations.</p> <ol class="p-article__faculty-referee-list t-caption"> <li> <p class=" u-mt--0 u-mb--1/2"><strong>St&eacute;phane Bolduc</strong>, Division of Urology, CHU de Québec-Université Laval, Canada </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> <li> <p class=" u-mt--0 u-mb--1/2"><strong>Linda Cardozo</strong>, Urogynaecology Department, King's College London, UK </p> <div class="c-read-more js-read-more " data-lines=3> <div class="c-read-more__content js-read-more-content "> <p class="u-mt--0 u-mb--0 p-article__color--light"> <strong class=u-weight--md>Competing interests:</strong> No competing interests were declared. </p> </div> <a href="#" class="c-read-more__toggle js-read-more-toggle t-caption"> <span class=c-read-more__expand>View more</span> <span class=c-read-more__contract>View less</span> </a> </div> </li> </ol> </div> </div> <section class="o-layout__item u-pl"> <div class=u-pl> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--2">Comments on this article</h4> <div class=u-mb--4> <p class="u-mt--0 u-mb--1 t-h4"><a class=p-article__color--light href="#article-comments">All Comments</a><span class=" u-ib u-ml--1/2 p-article__color--light">(0)</span></p> <a class=t-h4 href="/login?originalPath=/articles/6-2148/v1&scrollTo=add-new-comment" data-test-id=add-comment>Add a comment</a> </div> <hr class="c-hr c-hr--low c-hr--md u-mb--4"> <div class="research-layout f1r-article-desk"> <div class="heading6 c-ribbon-wrapper c-ribbon-wrapper--etoc f1000research "> <div class=c-ribbon-wrapper__body>Sign up for content alerts</div> </div> </div> <div class="research-layout sidebar-sign-up-form f1r-article-desk u-mb--4 "> <form class=js-email-alert-signup action="#" method=POST data-email=tocAlertWeekly> <input type=hidden name=isUserLoggedIn class=js-email-alert-signup-logged-in value=N /> <input type=hidden name=userId class=js-email-alert-signup-user-id value=""/> <input type=hidden name=frequency class=js-email-alert-signup-frequency value=WEEKLY /> <div class="o-actions o-actions--middle"> <div class=o-actions__primary> <input type=email name=emailAddress class="form-input-field js-email-alert-signup-address u-1/1 u-bb" required=required placeholder=Email /> </div> <div class=o-actions__secondary> <div class="_mdl-layout u-ml--1/2"> <button class="mdl-button mdl-js-button mdl-button--colored mdl-button--small mdl-button--filled js-email-alert-signup-submit">Sign Up</button> </div> </div> </div> </form> <div id=sidebar-sign-up-message class="section-text js-email-alert-signup-msg is-hidden">You are now signed up to receive this alert</div> </div> <section class=js-terms-container> <hr class="c-hr c-hr--low c-hr--md u-mb--3"> <h4 class="t-h3 u-weight--md u-mt--0 u-mb--1">Browse by related subjects</h4> <div class="article-subcontainer article-subcontainer--sidebar"> <ul class=js-terms-list></ul> </div> </section> </div> </section> </div> </section> </div> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/read-more.js"></script> <script src="/js/article/article-router.js"></script> <script src="/js/article/article-sidebar.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/article/article-column-toggle.js"></script> </div> </div> </div> </main> <input type=hidden id=_articleVersionUrl value="https://f1000research.com/articles/6-2148/v1/"> <div class=research-help id=about-referee-status> <div class="research-layout research-help-content about-referee-status"> <span class="close-research-help dark-cross" title=Close></span> Alongside their report, reviewers assign a status to the article: <div class="cf research-help-row"> <span class="f1r-icon icon-86_approved status-green smaller" title=Approved></span> <span class=research-help-text>Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested</span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-87_approved_reservations status-green smaller" title="Approved with Reservations"></span> <span class=research-help-text>Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit. </span> </div> <div class="cf research-help-row"> <span class="f1r-icon icon-88_not_approved status-red small" title="Not Approved"></span> <span class=research-help-text>Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions</span> </div> </div> </div> <div id=datasets-info class=is-hidden> </div> <div class=article-interactive-content-container style="display: none;"> <a name=f-template class=n-a></a> <div class="interactive-content-wrapper padding-20"> <img src="" class=interactive-content-image title="Open the interactive image display"> <div class=interactive-content-title></div> <div class=interactive-content-text></div> <div class="f1r-article-desk interactive-content-ribbon" data-interactive-content-type=R-Script> <div class=interactive-content-label>Adjust parameters to alter display</div> <div class=interactive-content-button></div> </div> <div class="f1r-article-mobile mobile-interactive-note"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div id=article-interactive-omero-container class=article-interactive-omero-container style="display: none;"> <div class=interactive-content-wrapper> <div class="interactive-omero-button omero-content" title="Open the interactive content window." data-interactive-content-type=Omero></div> <div class=has-interactive-content-image> <span class=box-arrow></span> <span class=box-middle>Includes Interactive Elements</span> <span class=box-end></span> </div> <div class="fig panel clearfix" style="margin: 0; padding-bottom: 20px;"> <a name=templatelink class=n-a></a> <a target=_blank href="" class=link-for-omero-image> <img src="" class=interactive-omero-image title="Open the image display window."> </a> <div class=caption> <div class=interactive-content-title></div> <div class=interactive-content-text></div> </div> <div class="is-hidden omero-image-list"></div> </div> <div class="f1r-article-mobile mobile-interactive-note omero"> View on desktop for interactive features <img src="/img/icon/interactive_content.png" class="float-right margin-right-40"/> </div> <div class=clearfix></div> </div> </div> <div class="add-comment-container shadow-box is-hidden" id=save-comment-container> <span id=save-comment-text class=intro-text>Edit comment</span> <textarea id=new-comment name=new-comment class="global-textarea comment margin-bottom margin-top"></textarea> <p><strong>Competing Interests</strong></p> <textarea id=new-competing-interests name=competing-interests class="global-textarea competing-interests margin-bottom check-xss"></textarea> <div class=clearfix></div> <button id=cancelComment type=button class="general-white-orange-button float-right no-background-button margin-left"> Cancel </button> <button id=save-comment-button commentId="" type=button class="general-white-orange-button float-right"> Save </button> <div class=clearfix></div> <div class="green-message margin-top is-hidden comment-is-saved">The comment has been saved.</div> <div class="red-message margin-top is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class="red-message margin-top is-hidden comment-enter-text ucf">Your must enter a comment.</div> <div class="red-message margin-top is-hidden comment-references-error references">References error.</div> </div> <div class="modal-window-wrapper is-hidden"> <div id=conflicts-interests class="modal-window padding-20"> <div class=modal-window__content> <h2 class=h2-title>Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div class="f1r-article-mobile research-layout"> <span class=modal-window-close-button></span> </div> </div> </div> <div class="o-modal c-email-alert-popup js-email-alert-popup is-hidden"> <div class="o-modal__body js-modal-body c-email-alert-popup__inner"> <h3 class=c-email-alert-popup__title>Stay Updated</h3> <p class=c-email-alert-popup__sub>Sign up for content alerts and receive a weekly or monthly email with all newly published articles</p> <p><a href="/register?originalPath=" class="c-email-alert-popup__lnk c-email-alert-popup__button js-email-alert-popup-action">Register with F1000Research</a></p> <p>Already registered? <a href="/login?originalPath=" class="c-email-alert-popup__lnk js-email-alert-popup-action">Sign in</a></p> <p class=c-email-alert-popup__footer><a class="c-email-alert-popup__lnk js-email-alert-popup-cancel" href="#">Not now, thanks</a></p> </div> </div> <div id=addCommentModal role=dialog aria-labelledby=addCommentModal_title aria-describedby=addCommentModal_description> <div class="c-modal js-modal is-closed p-article__add-comment-modal c-modal--xlarge js-article-comment-modal c-modal--scroll "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-bg--2 c-modal--scroll-always "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <div id=addCommentModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div class="js-add-comment-container t-caption u-black--high"> <div class=u-weight--bd>PLEASE NOTE</div> <div class=u-mt--1> <span class="red u-weight--bd">If you are an AUTHOR of this article,</span> please check that you signed in with the account associated with this article otherwise we cannot automatically identify your role as an author and your comment will be labelled as a &ldquo;User Comment&rdquo;. </div> <div class=u-mt--1> <span class="red u-weight--bd">If you are a REVIEWER of this article,</span> please check that you have signed in with the account associated with this article and then go to your <a href="/my/referee">account</a> to submit your report, please do not post your review here. </div> <div class="u-mt--1 u-mb--1"> If you do not have access to your original account, please <a href="mailto:research@f1000.com">contact us</a>. </div> <p class=no-top-margin>All commenters must hold a formal affiliation as per our <a href="/about/policies#commentspolicy" target=_blank>Policies</a>. The information that you give us will be displayed next to your comment.</p> <p>User comments must be in English, comprehensible and relevant to the article under discussion. We reserve the right to remove any comments that we consider to be inappropriate, offensive or otherwise in breach of the <a href="/about/legal/usercommenttermsandconditions" target=_blank>User Comment Terms and Conditions</a>. Commenters must not use a comment for personal attacks. When criticisms of the article are based on unpublished data, the data should be made available.</p> <div class="comments-note margin-bottom" id=accept-user-comments> <input class=js-add-comment-accept-terms type=checkbox id=acceptedTermsAndConditions name=acceptedTermsAndConditions> I accept the <a href="/about/legal/usercommenttermsandconditions" target=_blank> User Comment Terms and Conditions</a> <span class=required>&nbsp;</span> </div> <div class="default-error margin-top is-hidden comment-accept-conditions utac">Please confirm that you accept the User Comment Terms and Conditions.</div> <div class="research-layout registration-form u-mb--2"> <div class="u-mb--1 u-mt--2"> <strong>Affiliation</strong> </div> <div class=form-field> <input type=text name=institution class="form-input-field check-xss js-add-comment-institution" placeholder="Organization *" autocomplete=off /> <div class="default-error margin-top is-hidden comment-enter-institution institution">Please enter your organisation.</div> </div> <div class=form-field> <input type=text name=place class="form-input-field check-xss js-add-comment-place" placeholder=Place> </div> <div class=form-field> <div class="form-input-wrapper hundred-percent-wide"> <div class="new-select-standard-wrapper half-width inline-display heading10"> <select name=countryId id=country class="form-select-menu smaller js-add-comment-country"> <option value=-1>Country*</option> <option value=840>USA</option> <option value=826>UK</option> <option value=124>Canada</option> <option value=156>China</option> <option value=250>France</option> <option value=276>Germany</option> <optgroup label=-----------------------------------------------></optgroup> <option value=4>Afghanistan</option> <option value=248>Aland Islands</option> <option value=8>Albania</option> <option value=12>Algeria</option> <option value=16>American Samoa</option> <option value=20>Andorra</option> <option value=24>Angola</option> <option value=660>Anguilla</option> <option value=10>Antarctica</option> <option value=28>Antigua and Barbuda</option> <option value=32>Argentina</option> <option value=51>Armenia</option> <option value=533>Aruba</option> <option value=36>Australia</option> <option value=40>Austria</option> <option value=31>Azerbaijan</option> <option value=44>Bahamas</option> <option value=48>Bahrain</option> <option value=50>Bangladesh</option> <option value=52>Barbados</option> <option value=112>Belarus</option> <option value=56>Belgium</option> <option value=84>Belize</option> <option value=204>Benin</option> <option value=60>Bermuda</option> <option value=64>Bhutan</option> <option value=68>Bolivia</option> <option value=70>Bosnia and Herzegovina</option> <option value=72>Botswana</option> <option value=74>Bouvet Island</option> <option value=76>Brazil</option> <option value=86>British Indian Ocean Territory</option> <option value=92>British Virgin Islands</option> <option value=96>Brunei</option> <option value=100>Bulgaria</option> <option value=854>Burkina Faso</option> <option value=108>Burundi</option> <option value=116>Cambodia</option> <option value=120>Cameroon</option> <option value=124>Canada</option> <option value=132>Cape Verde</option> <option value=136>Cayman Islands</option> <option value=140>Central African Republic</option> <option value=148>Chad</option> <option value=152>Chile</option> <option value=156>China</option> <option value=162>Christmas Island</option> <option value=166>Cocos (Keeling) Islands</option> <option value=170>Colombia</option> <option value=174>Comoros</option> <option value=178>Congo</option> <option value=184>Cook Islands</option> <option value=188>Costa Rica</option> <option value=384>Cote d'Ivoire</option> <option value=191>Croatia</option> <option value=192>Cuba</option> <option value=196>Cyprus</option> <option value=203>Czech Republic</option> <option value=180>Democratic Republic of the Congo</option> <option value=208>Denmark</option> <option value=262>Djibouti</option> <option value=212>Dominica</option> <option value=214>Dominican Republic</option> <option value=218>Ecuador</option> <option value=818>Egypt</option> <option value=222>El Salvador</option> <option value=226>Equatorial Guinea</option> <option value=232>Eritrea</option> <option value=233>Estonia</option> <option value=231>Ethiopia</option> <option value=238>Falkland Islands</option> <option value=234>Faroe Islands</option> <option value=583>Federated States of Micronesia</option> <option value=242>Fiji</option> <option value=246>Finland</option> <option value=250>France</option> <option value=254>French Guiana</option> <option value=258>French Polynesia</option> <option value=260>French Southern Territories</option> <option value=266>Gabon</option> <option value=268>Georgia</option> <option value=276>Germany</option> <option value=288>Ghana</option> <option value=292>Gibraltar</option> <option value=300>Greece</option> <option value=304>Greenland</option> <option value=308>Grenada</option> <option value=312>Guadeloupe</option> <option value=316>Guam</option> <option value=320>Guatemala</option> <option value=831>Guernsey</option> <option value=324>Guinea</option> <option value=624>Guinea-Bissau</option> <option value=328>Guyana</option> <option value=332>Haiti</option> <option value=334>Heard Island and Mcdonald Islands</option> <option value=336>Holy See (Vatican City State)</option> <option value=340>Honduras</option> <option value=344>Hong Kong</option> <option value=348>Hungary</option> <option value=352>Iceland</option> <option value=356>India</option> <option value=360>Indonesia</option> <option value=364>Iran</option> <option value=368>Iraq</option> <option value=372>Ireland</option> <option value=376>Israel</option> <option value=380>Italy</option> <option value=388>Jamaica</option> <option value=392>Japan</option> <option value=832>Jersey</option> <option value=400>Jordan</option> <option value=398>Kazakhstan</option> <option value=404>Kenya</option> <option value=296>Kiribati</option> <option value=901>Kosovo (Serbia and Montenegro)</option> <option value=414>Kuwait</option> <option value=417>Kyrgyzstan</option> <option value=418>Lao People's Democratic Republic</option> <option value=428>Latvia</option> <option value=422>Lebanon</option> <option value=426>Lesotho</option> <option value=430>Liberia</option> <option value=434>Libya</option> <option value=438>Liechtenstein</option> <option value=440>Lithuania</option> <option value=442>Luxembourg</option> <option value=446>Macao</option> <option value=807>Macedonia</option> <option value=450>Madagascar</option> <option value=454>Malawi</option> <option value=458>Malaysia</option> <option value=462>Maldives</option> <option value=466>Mali</option> <option value=470>Malta</option> <option value=584>Marshall Islands</option> <option value=474>Martinique</option> <option value=478>Mauritania</option> <option value=480>Mauritius</option> <option value=175>Mayotte</option> <option value=484>Mexico</option> <option value=581>Minor Outlying Islands of the United States</option> <option value=498>Moldova</option> <option value=492>Monaco</option> <option value=496>Mongolia</option> <option value=499>Montenegro</option> <option value=500>Montserrat</option> <option value=504>Morocco</option> <option value=508>Mozambique</option> <option value=104>Myanmar</option> <option value=516>Namibia</option> <option value=520>Nauru</option> <option value=524>Nepal</option> <option value=530>Netherlands Antilles</option> <option value=540>New Caledonia</option> <option value=554>New Zealand</option> <option value=558>Nicaragua</option> <option value=562>Niger</option> <option value=566>Nigeria</option> <option value=570>Niue</option> <option value=574>Norfolk Island</option> <option value=580>Northern Mariana Islands</option> <option value=408>North Korea</option> <option value=578>Norway</option> <option value=512>Oman</option> <option value=586>Pakistan</option> <option value=585>Palau</option> <option value=275>Palestinian Territory</option> <option value=591>Panama</option> <option value=598>Papua New Guinea</option> <option value=600>Paraguay</option> <option value=604>Peru</option> <option value=608>Philippines</option> <option value=612>Pitcairn</option> <option value=616>Poland</option> <option value=620>Portugal</option> <option value=630>Puerto Rico</option> <option value=634>Qatar</option> <option value=638>Reunion</option> <option value=642>Romania</option> <option value=643>Russian Federation</option> <option value=646>Rwanda</option> <option value=654>Saint Helena</option> <option value=659>Saint Kitts and Nevis</option> <option value=662>Saint Lucia</option> <option value=666>Saint Pierre and Miquelon</option> <option value=670>Saint Vincent and the Grenadines</option> <option value=882>Samoa</option> <option value=674>San Marino</option> <option value=678>Sao Tome and Principe</option> <option value=682>Saudi Arabia</option> <option value=686>Senegal</option> <option value=688>Serbia</option> <option value=690>Seychelles</option> <option value=694>Sierra Leone</option> <option value=702>Singapore</option> <option value=703>Slovakia</option> <option value=705>Slovenia</option> <option value=90>Solomon Islands</option> <option value=706>Somalia</option> <option value=710>South Africa</option> <option value=239>South Georgia and the South Sandwich Is</option> <option value=410>South Korea</option> <option value=724>Spain</option> <option value=144>Sri Lanka</option> <option value=736>Sudan</option> <option value=740>Suriname</option> <option value=744>Svalbard and Jan Mayen</option> <option value=748>Swaziland</option> <option value=752>Sweden</option> <option value=756>Switzerland</option> <option value=760>Syria</option> <option value=158>Taiwan</option> <option value=762>Tajikistan</option> <option value=834>Tanzania</option> <option value=764>Thailand</option> <option value=270>The Gambia</option> <option value=528>The Netherlands</option> <option value=626>Timor-Leste</option> <option value=768>Togo</option> <option value=772>Tokelau</option> <option value=776>Tonga</option> <option value=780>Trinidad and Tobago</option> <option value=788>Tunisia</option> <option value=792>Turkey</option> <option value=795>Turkmenistan</option> <option value=796>Turks and Caicos Islands</option> <option value=798>Tuvalu</option> <option value=800>Uganda</option> <option value=826>UK</option> <option value=804>Ukraine</option> <option value=784>United Arab Emirates</option> <option value=850>United States Virgin Islands</option> <option value=858>Uruguay</option> <option value=840>USA</option> <option value=860>Uzbekistan</option> <option value=548>Vanuatu</option> <option value=862>Venezuela</option> <option value=704>Vietnam</option> <option value=876>Wallis and Futuna</option> <option value=905>West Bank and Gaza Strip</option> <option value=732>Western Sahara</option> <option value=887>Yemen</option> <option value=894>Zambia</option> <option value=716>Zimbabwe</option> </select> </div> </div> <div class="default-error margin-top is-hidden comment-enter-country country">Please select your country.</div> </div> </div> <textarea data-test-id=article_add-comment_comment name=new-comment class="js-add-comment-comment comment margin-bottom margin-top"></textarea> <div class="default-error margin-top comment-enter-text comment-error is-hidden ">You must enter a comment.</div> <label class="comments-note u-mt--2 u-mb--2" for=competingInterests_1> <div class="u-mb--1 u-mt--2"><strong data-test-id=article_report-add-comment_competing-interests-title>Competing Interests</strong></div> <p class="u-mb--2 u-mt--0" data-test-id=article_report-add-comment_competing-interests-description>Please disclose any <a href="#article-competing-intersts-policy" class=js-modal-competing-intersts-toggle>competing interests</a> that might be construed to influence your judgment of the article's or peer review report's validity or importance.</p> </label> <div id=article-competing-intersts-policy class=js-article-competing-interests-policy style="display: none;"> <h2 class="h2-title u-mt--0 u-pt--0">Competing Interests Policy</h2> <p> Provide sufficient details of any financial or non-financial competing interests to enable users to assess whether your comments might lead a reasonable person to question your impartiality. Consider the following examples, but note that this is not an exhaustive list: </p> <div class=heading5>Examples of 'Non-Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>Within the past 4 years, you have held joint grants, published or collaborated with any of the authors of the selected paper.</li> <li class=standard-padding>You have a close personal relationship (e.g. parent, spouse, sibling, or domestic partner) with any of the authors.</li> <li class=standard-padding>You are a close professional associate of any of the authors (e.g. scientific mentor, recent student).</li> <li class=standard-padding>You work at the same institute as any of the authors.</li> <li class=standard-padding>You hope/expect to benefit (e.g. favour or employment) as a result of your submission.</li> <li class=standard-padding>You are an Editor for the journal in which the article is published.</li> </ol> <div class="heading5 padding-top">Examples of 'Financial Competing Interests'</div> <ol class="numbered-list no-padding"> <li class=standard-padding>You expect to receive, or in the past 4 years have received, any of the following from any commercial organisation that may gain financially from your submission: a salary, fees, funding, reimbursements.</li> <li class=standard-padding>You expect to receive, or in the past 4 years have received, shared grant support or other funding with any of the authors.</li> <li class=standard-padding>You hold, or are currently applying for, any patents or significant stocks/shares relating to the subject matter of the paper you are commenting on.</li> </ol> </div> <div id=competingInterests_1 class="c-inline-editor js-inline-editor js-form_input u-bb--all u-mb--2 js-comment-competing-interests" data-name=competing-interests data-rows=3> <textarea id=competingInterests_1_input name=competing-interests placeholder="&nbsp;" required=false class="u-hide-visually js-inline-editor_input" tabindex=-1></textarea> <div class="c-inline-editor__editor js-inline-editor_editor o-box c-box o-box--tiny u-bg--11" data-target=competingInterests_1_input role=textbox required=false data-placeholder="&nbsp;" contenteditable=true></div> <span class="c-inline-editor__error js-inline-editor-message">Please state your competing interests</span> </div> <div data-test-id=article_add-comment_saved class="green-message comments is-hidden comment-is-saved">The comment has been saved.</div> <div data-test-id=article_add-comment_error class="default-error comments is-hidden comment-not-added">An error has occurred. Please try again.</div> <div class=clearfix></div> <div class=js-hook></div> </div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" data-test-id=article_add-comment_cancel class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" data-test-id=article_add-comment_post class="c-button c-button--full js-modal__confirm c-button--primary">Post</a> </div> </aside> </div> </div> <style>
                .at-icon-wrapper {
        background-size: 100% !important;
    }
</style> <script src="/js/namespace.js"></script> <script src="/js/constants.js"></script> <script src="/js/utilities.js"></script> <script src="/js/article/alert-signup.js"></script> <script type='text/javascript'>
    var lTitle = "Recent advances in pharmacological management...".replace("'", '');
    var linkedInUrl = "http://www.linkedin.com/shareArticle?url=https://f1000research.com/articles/6-2148/v1" + "&title=" + encodeURIComponent(lTitle) + "&summary=" + encodeURIComponent('Read the article by ');

    var deliciousUrl = "https://del.icio.us/post?url=https://f1000research.com/articles/6-2148/v1&title=" + encodeURIComponent(lTitle);

    var redditUrl = "http://reddit.com/submit?url=https://f1000research.com/articles/6-2148/v1" + "&title=" + encodeURIComponent(lTitle);

            linkedInUrl += encodeURIComponent('McDonnell B and Birder LA');
    
    var offsetTop = /chrome/i.test( navigator.userAgent ) ? 4 : -10; 
    var addthis_config = {
            ui_offset_top: offsetTop,
                                    services_compact : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_expanded : "facebook,twitter,www.linkedin.com,www.mendeley.com,reddit.com",
            services_custom : [
                {
                    name: "LinkedIn",
                    url:  linkedInUrl,
                    icon:"/img/icon/at_linkedin.svg"
                },
                {
                    name: "Mendeley",
                    url:  "http://www.mendeley.com/import/?url=https://f1000research.com/articles/6-2148/v1/mendeley",
                    icon:"/img/icon/at_mendeley.svg"
                },
                {
                    name: "Reddit",
                    url:  redditUrl,
                    icon:"/img/icon/at_reddit.svg"
                },
            ]
        };


    var addthis_share = {
            url: "https://f1000research.com/articles/6-2148",
            templates : {
                twitter : "Recent advances in pharmacological management of urinary incontinence. McDonnell B and Birder LA, published by " + 
               "@F1000Research"
       + ", https://f1000research.com/articles/6-2148/v1"
            }
        };

    if (typeof(addthis) != "undefined"){
        addthis.addEventListener('addthis.ready', checkCount);
        addthis.addEventListener('addthis.menu.share', checkCount);
    }

        $(".f1r-shares-twitter").attr("href", "https://twitter.com/intent/tweet?text=" + addthis_share.templates.twitter);
    $(".f1r-shares-facebook").attr("href", "https://www.facebook.com/sharer/sharer.php?u=" + addthis_share.url);
    $(".f1r-shares-linkedin").attr("href", addthis_config.services_custom[0].url);
    $(".f1r-shares-reddit").attr("href", addthis_config.services_custom[2].url);
    $(".f1r-shares-mendelay").attr("href", addthis_config.services_custom[1].url);

    function checkCount(){
        setTimeout(function(){
            $(".addthis_button_expanded").each(function(){
                var count = $(this).text();
                if (count !== "" && count != "0")
                    $(this).removeClass("is-hidden");
                else
                    $(this).addClass("is-hidden");
            });
        }, 1000);
    }
</script> <div id=citeReportModal role=dialog aria-labelledby=citeReportModal_title aria-describedby=citeReportModal_description> <div class="c-modal js-modal is-closed c-modal--large js-cite-report-modal "> <aside class="c-modal__content u-black--high o-box u-pb--0 u-black--high "> <div class=c-modal__close> <button type=button class="c-button c-button--icon c-button--medium c-button--full@hover js-modal__close"><i class="c-button--icon__icon material-icons">close</i></button> </div> <h1 id=citeReportModal_title class="c-modal__title t-h3 u-mt--0 u-mb--2 u-weight--md">How to cite this report</h1> <div id=citeReportModal_description class="c-modal__description js-modal__content t-h4 u-mt--0 u-mb--2 u-black--medium"> <div id="" class=js-report-citation-container>{{reportCitation}}</div> <div class="c-modal__extra-message js-modal__extra-message t-h4 u-black--medium"></div></div> <div class="c-modal__actions o-box__actions"> <a href="#" class="c-button c-button--full js-modal__close c-button--secondary">Cancel</a> <a href="#" title="Copy the current citation details to the clipboard." data-clipboard-target="#referee-report-citation" data-test-id=report_copy-citation_button class="c-button c-button--full js-modal__confirm c-button--primary js-clipboard c-mini-tooltip--above">Copy Citation Details</a> </div> </aside> </div> </div> <script src="/js/referee/new/referee_validators.js"></script> <script src="/js/referee/new/referee_helpers.js"></script> <script src="/js/referee/new/referee_checkbox-input.js"></script> <script src="/js/referee/new/referee_inline-editor.js"></script> <script type="text/javascript">
    $(function(){
        var gaCat = "F1000Research";
        if (gaCat === "") {
            gaCat = $("body").hasClass("wellcome-brand") ? "Wellcome Open Research" : "F1000Research";
        }
        GAHelper.track({category: gaCat, action: "Article Page: Recent advances in pharmacological management of urinary incontinence", label: "pageviews"});
        GAHelper.track({category: gaCat, action: "Article Type: Review", label: "Article Page"});
        $(".f1r-article-desk .collection-image").each(function (idx, el) {
            var whatChannel = $(el).find("a").attr("href"),
                channelName = $.trim($(el).parent().find(".collection-detail a").text()),
                gaRef = "(ID: " + whatChannel.replace("/collections/", "") + ") " + channelName;
            GAHelper.track({category: 'ChannelStats', action: "Article Page: Recent advances in pharmacological management of urinary incontinence", label: gaRef});
        });
    });
</script> <script>
    $(function(){R.ui.buttonDropdowns('.dropdown-for-downloads');});
    $(function(){R.ui.toolbarDropdowns('.toolbar-dropdown-for-downloads');});
</script> <script src="/js/article/track_article.js" type="text/javascript"></script> <script type="text/javascript">
    $.get("/articles/acj/12593/13637")
</script> <script type="text/javascript" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script type="text/javascript" src="/js/app/messenger.js"></script> <script type="text/javascript" src="/js/article/article_mobiles.js"></script> <script src="/js/vendor/clipboard.min.js"></script> <script src="/js/shared_scripts/modal-dialogue.js"></script> <script src="/js/shared_scripts/clipboard.js"></script> <script src="/js/article/thesaurus-terms-display.js"></script> <script>
    new F1000.Clipboard();
    new F1000.ThesaurusTermsDisplay("faculty-reviews", "article", "13637");
</script> <script>
    $(document).ready(function() {
        $( "#frame1" ).on('load', function() {
            var mydiv = $(this).contents().find("div");
            var h     = mydiv.height();
            console.log(h)
        });

        
        var tooltipLivingFigure = jQuery(".interactive-living-figure-label .icon-more-info"),
            titleLivingFigure = tooltipLivingFigure.attr("title");
        tooltipLivingFigure.simpletip({
            fixed: true,
            position: ["-115", "30"],
            baseClass: 'small-tooltip',
            content:titleLivingFigure + "<div class='tooltip-arrow'></div>"
        });
        tooltipLivingFigure.removeAttr("title");

        $("body").on("click", ".cite-living-figure", function(e) {
            e.preventDefault();
            var ref = $(this).attr("data-ref");
            $(this).closest(".living-figure-list-container").find("#" + ref).fadeIn(200);
        });
        $("body").on("click", ".close-cite-living-figure", function(e) {
            e.preventDefault();
            $(this).closest(".popup-window-wrapper").fadeOut(200);
        });

                $(document).on("mouseup", function(e) {
            var metricsContainer = $(".article-metrics-popover-wrapper");
            if (!metricsContainer.is(e.target) && metricsContainer.has(e.target).length === 0) {
                $(".article-metrics-close-button").click();
            }
        });

        var articleId = $('#articleId').val();

        if($("#main-article-count-box").attachArticleMetrics) {
            $("#main-article-count-box").attachArticleMetrics(articleId, {
                articleMetricsView: true
            });
        }
    });

    var figshareWidget = $(".new_figshare_widget");
    if (figshareWidget.length > 0) {
        window.figshare.load("f1000", function(Widget) {
            // Select a tag/tags defined in your page. In this tag we will place the widget.
            _.map(figshareWidget, function(el){
                var widget = new Widget({
                    articleId: $(el).attr("figshare_articleId")
                    //height:300 // this is the height of the viewer part. [Default: 550]
                });
                widget.initialize(); // initialize the widget
                widget.mount(el); // mount it in a tag that's on your page
                // this will save the widget on the global scope for later use from
                // your JS scripts. This line is optional.
                //window.widget = widget;
            });
        });
    }
</script>

<script>
    $(document).ready(function () {

        
        var reportIds = {
                           "29057": 0,
                           "29058": 0,
                    };

        $(".referee-response-container,.js-referee-report").each(function(index, el) {
            var reportId = $(el).attr("data-reportid"),
                reportCount = reportIds[reportId] || 0;
            $(el).find(".comments-count-container,.js-referee-report-views").html(reportCount);
        });

        var uuidInput = $("#article_uuid"),
            oldUUId = uuidInput.val(),
            newUUId = "5d5b50bf-582e-4706-8dc0-69d1bb6340af";
        uuidInput.val(newUUId);

        $("a[href*='article_uuid=']").each(function(index, el) {
            var newHref = $(el).attr("href").replace(oldUUId, newUUId);
            $(el).attr("href", newHref);
        });

    });
</script>              </div>
        </div>

        
            
            <div class="o-page__footer sticky-email-wrapper">
                
                

                


<footer class="c-footer t-inverted">

    <div class="o-wrapper">
        <div class="o-layout">


                        
            <div class="o-layout__item u-mb--3">
                <div class="c-branding c-branding--research">
                    <img src="/img/research/F1000Research_white.svg" alt="F1000Research">
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <p class="t-h3 u-mt--0 u-mb--0">An innovative open access publishing platform offering rapid publication and open peer review, whilst supporting data deposition and sharing.</p>

            </div>


                        
            <div class="o-layout__item u-2/3@md">

                <span class="c-hr c-hr--thick c-hr--low u-mb--2"></span>

                <div class="o-layout">
                    <nav class="c-footer__nav">

                            <div class="o-layout__item u-3/5@sm u-mb--3">


                                <div class="o-columns o-columns--2">

                                                                            <a href="/browse/articles" class="t-body c-footer__nav-item "      >Browse</a>
                                                                            <a href="/gateways" class="t-body c-footer__nav-item "      >Gateways</a>
                                                                            <a href="/collections" class="t-body c-footer__nav-item "      >Collections</a>
                                                                            <a href="/about" class="t-body c-footer__nav-item "      >How it Works</a>
                                                                            <a href="https://blog.f1000.com/blogs/f1000research/" class="t-body c-footer__nav-item "      >Blog</a>
                                                                            <a href="/contact" class="t-body c-footer__nav-item "      >Contact</a>
                                                                            <a href="/developers" class="t-body c-footer__nav-item u-hide u-show@navbar"      >For Developers</a>
                                                                            <a href="/published/rss" class="t-body c-footer__nav-item "   title="RSS feed of published articles"     >RSS</a>
                                    
                                </div>

                            </div>

                            <div class="o-layout__item u-2/5@sm u-center u-right@sm u-mb--3">

                                <div class="u-hide u-show@lg">
                                    <div class="_mdl-layout">
                                        <a class="mdl-button mdl-js-button mdl-button--inverted mdl-button--no-shadow mdl-js-ripple-effect mdl-button--outline" href="/for-authors/publish-your-research"   data-test-id="footer_submit_research"  >Submit Your Research</a>
                                    </div>
                                </div>

                            </div>

                    </nav>
                </div>

            </div>

            <div class="o-layout__item u-mb--2">
                <div class="c-footer__share">
                        <div class="c-footer__share">
        <span class="c-footer__share-icon" title="Open Access">
            <span class="f1r-icon icon-100_open_access license-icon"></span>
        </span>

        <a class="c-footer__share-icon" href="//creativecommons.org/licenses" target="_blank" title="Creative Commons License CC-BY">
            <span class="f1r-icon icon-116_cc license-icon license-icon-cc"></span>
            <span class="f1r-icon icon-117_ccby license-icon license-icon-cc"></span>
        </a>

        <a class="c-footer__share-icon" href="//creativecommons.org/about/cc0" target="_blank" title="Creative Commons License CC0">
            <span class="f1r-icon icon-118_cco license-icon"></span>
        </a>

    </div>
                </div>
            </div>


                        
            <div class="o-layout__item u-1/3@md u-mb--3">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="c-footer__social u-mt--0 u-mb--0 u-white--low-med">Follow us
                    <a href="https://www.facebook.com/F1000" target="_blank" class="c-footer__social-icon f1r-icon icon-55_footer_facebook"></a>
                    <a href="https://twitter.com/#!/F1000Research" target="_blank" class="c-footer__social-icon f1r-icon icon-56_footer_twitter"></a>
                    <a href="http://www.youtube.com/user/F1000research" target="_blank" class="c-footer__social-icon f1r-icon icon-57_footer_youtube"></a></p>

            </div>


                        
            <div class="o-layout__item u-2/3@md u-right@md">

                <span class="c-hr c-hr--low u-mb--3"></span>

                <p class="t-caption u-white--low-med">&copy; 2012-2020 F1000 Research Ltd. ISSN 2046-1402 | <a href="/about/legal" class="copyrightLegal">Legal</a> | Partner of <a target="_blank" href="http://www.who.int/hinari/en/">HINARI</a>  &bull; <a target="_blank" href="http://crossref.org/">CrossRef</a> &bull; <a target="_blank" href="http://about.orcid.org/">ORCID</a> &bull; <a target="_blank" href="http://www.fairsharing.org">FAIRSharing</a></p>

            </div>
        </div>
    </div>

</footer>            </div>
        
    </div>

            <div class="js-cookie-spacer"></div>
        <div class="cookie-warning">
            <div class="instruction">The F1000Research website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. <a class="js-scroll-to" href="/about/legal/privacypolicy#use-of-cookies" data-scroll-target="#use-of-cookies">Find out more &raquo;</a></div>
            <div class="close-button"></div>
        </div>
    
    <script>
                    R.templateTests.simpleTemplate = R.template('<p class="$variable.one">$text</p><p class="${variable.two}">$text</p><p class="$!variable.three">$text</p><p class="$!{variable.four}">$text</p><p class="${selector}.five">$text</p>');
            R.templateTests.runTests();
        
        var F1000platform = new F1000.Platform({
            name: "f1000research",
            displayName: "F1000Research",
            hostName: "f1000research.com",
            id: "1",
            editorialEmail: "research@f1000.com",
            infoEmail: "info@f1000.com",
            usePmcStats: true
        });

                    $(function(){R.ui.dropdowns('.dropdown-for-authors, .dropdown-for-about, .dropdown-for-myresearch');});
            // $(function(){R.ui.dropdowns('.dropdown-for-referees');});

            $(document).ready(function () {
                if ($(".cookie-warning").is(":visible")) {
                    $(".sticky").css("margin-bottom", "35px");
                    $(".devices").addClass("devices-and-cookie-warning");
                }
                $(".cookie-warning .close-button").click(function (e) {
                    $(".devices").removeClass("devices-and-cookie-warning");
                    $(".sticky").css("margin-bottom", "0");
                });

                $("#tweeter-feed .tweet-message").each(function (i, message) {
                    var self = $(message);
                    self.html(linkify(self.html()));
                });

                $(".partner").on("mouseenter mouseleave", function() {
                    $(this).find(".gray-scale, .colour").toggleClass("is-hidden");
                });
            });
        
    </script>

            
<div class="sign-in-popup">
	<!-- <a href="#" class="sign-in shadow">Sign in <span class="sign-in-image-active"></span></a> -->
	<a href="#" class="sign-in ${locale}">Sign In <span class="arrow-closed sign-in-arrow-padding arrow-opened"></span></a>
	<div class="sign-in-form">

            <form action="https://f1000research.com/j_spring_oauth_security_check" id="googleOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2148.html"/>
                            <input id="google-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-google" name="system" type="hidden" value="GOOGLE"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="facebookOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2148.html"/>
                            <input id="facebook-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-fb" name="system" type="hidden" value="FACEBOOK"/>
    </form>
            <form action="https://f1000research.com/j_spring_oauth_security_check" id="orcidOAuth" method="post"  target="_top" >
                                    <input class="target-field" type="hidden" name="target" value="/articles/6-2148.html"/>
                            <input id="orcid-remember-me" name="_spring_security_oauth_remember_me" type="hidden" value="true"/>
        <input id="system-orcid" name="system" type="hidden" value="ORCID"/>
    </form>
		<form id="sign-in-form" class="login-container" action="https://f1000research.com/login" method="post" name="f">
           <div id="sign-in-form-gfb-popup"></div>

                                                            <input class="target-field" type="hidden" name="target" value="/articles/6-2148.html"/>
                            			<input type="text" name="username" id="signin-email-box" class="sign-in-input" placeholder="Email address" autocomplete="email">
			<input type="password" name="password" id="signin-password-box" class="sign-in-input" placeholder="Password" autocomplete="current-password">
			<div class="sign-in-remember">
                <div class="checkbox-wrapper">
    				<input type="checkbox" id="remember-me" name="remember_me" class="checkbox is-hidden">
                </div>
                <span class="checkbox-label">Remember me</span>
			</div>
			<a href="#" class="sign-in-link" id="forgot-password-link">Forgotten your password?</a>
			<div class="sign-in-button-container margin-top margin-left-20 margin-bottom">
				<button type="submit" id="sign-in-button" class="sign-in-buttons general-white-orange-button">Sign In</button>
				<button type="button" id="sign-in-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
				<div class="clearfix"></div>
			</div>
			<div class="sign-in-error">Email or password not correct. Please try again</div>
			<div class="sign-in-loading">Please wait...</div>
		</form>
		<div class="forgot-password-container">
			
<script type="text/javascript">
	$(function(){
		// Note: All the setup needs to run against a name attribute and *not* the id due the clonish
		// nature of facebox...
		$("a[id=googleSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("GOOGLE");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=facebookSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("FACEBOOK");
            $("form[id=oAuthForm]").submit();
        });
        $("a[id=orcidSignInButton]").click(function(event){
            event.preventDefault();
            $("input[id=oAuthSystem]").val("ORCID");
            $("form[id=oAuthForm]").submit();
        });
	});
</script>

<span class="text first">
	If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.
    <p>The email address should be the one you originally registered with F1000.</p>
</span>
<input name="email" class="sign-in-input" id="email-forgot-password" type="text" placeholder="Email address">
<div class="forgot-password-email-error">
	Email address not valid, please try again
</div>
<div class="forgot-password-google-email-error">
    <p>You registered with F1000 via Google, so we cannot reset your password.</p>
	<p>To sign in, please click <a href="#" id="googleSignInButton">here</a>.</p>
    <p>If you still need help with your Google account password, please click <a href="https://www.google.com/accounts/recovery">here</a>.</p>
</div>
<div class="forgot-password-facebook-email-error">
    <p>You registered with F1000 via Facebook, so we cannot reset your password.</p>
    <p>To sign in, please click <a href="#" id="facebookSignInButton">here</a>.</p>
	<p>If you still need help with your Facebook account password, please click <a href="https://www.facebook.com/recover/initiate">here</a>.</p>
</div>
<div class="clearfix"></div>
<div class="forgot-password-captcha-error">
	Code not correct, please try again
</div>
<div class="clearfix"></div>
<div class="sign-in-button-container margin-left-20 margin-bottom">
	<button type="button" id="sign-in-reset-password" class="sign-in-buttons general-white-orange-button">Reset password</button>
	<button type="button" id="forgot-password-cancel" class="sign-in-buttons sign-in-cancel-button margin-left">Cancel</button>
	<div class="clearfix"></div>
</div>
<span class="text last">
	<a href="mailto:">Email us</a> for further assistance.
</span>
<form action="https://f1000research.com/j_spring_oauth_security_check" id="oAuthForm" method="post" target="_top">
                        <input class="target-field" type="hidden" name="target" value="/articles/6-2148.html"/>
                <input id="oAuthSystem" name="system" type="hidden"/>
</form>
			<div class="forgot-password-server-error">Server error, please try again.</div>
			<div class="sign-in-success">
                <p>We have sent an email to <span id="email-value"></span>, please follow the instructions to reset your password.</p>
                <p>If you don't receive this email, please check your spam filters and/or contact .</p>
            </div>
			<div class="sign-in-loading">Please wait...</div>
		</div>

		<div class="sign-in-form-register-section">
			<div class="sign-in-button-container margin-left-20 margin-bottom">
				<a href="/register" title="Register"><button type="button" id="sign-in-register-button" class="sign-in-buttons general-white-orange-button">Register</button></a>
				<div class="clearfix"></div>
			</div>
		</div>

	</div>
</div>

<script type="text/javascript">
$(document).ready(function () {

    signIn.createSignInAsRow($("#sign-in-form-gfb-popup"));

    $(".target-field").each(function () {
        var uris = $(this).val().split("/");
        if (uris.pop() === "login") {
        	$(this).val(uris.toString().replace(",","/"));
        }
    });
});
</script>
        <div id="templateOverlay" class="is-hidden" hidden="hidden">
  <div class="o-overlay js-overlay is-hidden" hidden="hidden"></div>
</div>

<div id="templateExternalMessages" class="is-hidden" hidden="hidden">
  <div class="o-modal o-modal--auto@md js-external-messages is-hidden" hidden="hidden">
    <div class="o-modal__body">
      <section class="c-console">
        <div class="_mdl-layout c-console__bdy js-external-messages-body"></div>
        <footer class="_mdl-layout c-console__ftr o-flex o-flex--reverse js-external-messages-footer">
          <button type="button" class="mdl-button mdl-js-button mdl-button--raised mdl-button--colored c-console__btn js-external-messages-close" data-action="maintenance-close">I Understand</button>
        </footer>
      </section>
    </div>
  </div>
</div>

<script src="https://cdnjs.cloudflare.com/ajax/libs/moment.js/2.22.1/moment.min.js"></script>

<script src="/js/namespace.js"></script>
<script src="/js/constants.js"></script>
<script src="/js/utilities.js"></script>

<script>
                  F1000.ExtenalMaintenanceItems = [
    {
      start: '2018-12-10T14:21:00Z',
      end: '2018-12-13T16:00:00Z',
      msg: 'This site will be down for a short time on XX December. It is advisable not to start any submissions on that day or you may lose your work unless you save regularly.',
      cookieName: 'outage23122018',
      editor: false,
    }
  ];
</script>

<script src="/js/shared_scripts/cookie-helper.js"></script>
<script src="/js/shared_scripts/mdl-helper.js"></script>

<script src="/js/app/external-maintenance.js"></script>

                <script type="text/javascript">
            (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
            (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
            m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
            })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

            ga('create', 'UA-5646075-11', 'auto');
            ga('require', 'displayfeatures');
            ga('send', 'pageview');
        </script>
        
                <script type="text/javascript" src="/js/app/research.analytics.js"></script>

        <!-- Start of HubSpot Embed Code -->
        <script type="text/javascript" id="hs-script-loader" async defer src="//js.hs-scripts.com/4475190.js"></script>
        <!-- End of HubSpot Embed Code -->
    
            <script src="https://my.hellobar.com/4e0495c6f18cbd68731a1dc1978195a144e767ba.js" type="text/javascript" charset="utf-8" async="async"></script>
    </body>

</html>